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Rationale: Although studies using the California Verbal Learning Test (CVLT) 
have shown that recognition memory declines with age, age-related differences on more 
nuanced aspects of recognition have not been explored in detail. CVLT research also has 
 xxi 
shown that Alzheimer’s disease (AD) is associated with impaired recall and recognition 
that reflect an encoding deficit stemming from neuropathology in medial temporal 
cortices. Huntington’s disease (HD) is also associated with impaired recall but, in 
contrast to AD, in early stages shows less compromised recognition, reflecting primarily 
a retrieval deficit due to frontal-system dysfunction. Although original CVLT research 
demonstrated that recognition deficits are less severe in HD than in AD, more recent 
CVLT-II evidence has yielded mixed findings, highlighting the need for more refined 
measures to elucidate the extent of recognition memory impairment in AD and HD and 
thereby enhance characterizations of the profiles of memory loss associated with these 
neurodegenerative conditions. Method and Results: Study 1 examined whether AD and 
HD differences on the CVLT-II Total Recognition Discriminability (RD) index (which 
assesses the ability to distinguish List A [original word list] targets from all distractors on 
the Yes/No Recognition trial) varied across nonparametric (used in CVLT) and 
parametric (used in CVLT-II) calculations of Total RD. Comparisons of group 
differences on nonparametric versus parametric Total RD indices could only be done in 
the context of raw scores (the CVLT-II does not by default include a nonparametric Total 
RD index, and no standardized nonparametric Total RD scores were therefore available), 
and the magnitudes of group differences were not shown to significantly differ across 
nonparametric and parametric methods. However, in contrast to what was observed in 
prior CVLT studies, analyses indicated that relative to the AD group, the HD group 
exhibited comparable standardized parametric Total RD scores (despite higher raw 
nonparametric and parametric Total RD scores [after accounting for demographic factors 
when appropriate]). A potential explanation for the discrepancy in performance of 
 xxii 
individuals with HD on the CVLT versus CVLT-II recognition trials was that an 
increased proportion of prototypical distractors (i.e., those that are semantically related to 
targets) on the CVLT-II relative to the CVLT disproportionately amplified the difficulty 
of the recognition trial for individuals with frontal-system dysfunction (e.g., HD). Study 2 
investigated the utility of more refined RD indices generated to parse the degree of 
semantic association between targets and distractors (on Source and Novel RD indices 
that assess the ability to distinguish List A targets from List B [interference word list] and 
novel distractors, respectively) in characterizing nuanced aspects of yes/no recognition 
memory in healthy older and young adults. Although older adults performed worse than 
young adults on all RD indices, age group differences were smaller on more refined RD 
indices that excluded semantically-related distractors in RD calculations. Building on 
findings from Studies 1 and 2, Study 3 examined performance in individuals with AD and 
HD on Total RD and List A vs. Novel/Unrelated RD indices. The latter is a new index 
that isolates the ability to distinguish List A targets from distractors that are novel and 
semantically unrelated to targets. The List A vs. Novel/Unrelated RD index is therefore 
less subject than the Total RD index to source memory difficulties and semantic 
confusion, both of which are often seen in individuals with frontal-system dysfunction 
(e.g., HD), and may yield more purified assessments of yes/no recognition memory in 
HD. Analyses indicated that the List A vs. Novel/Unrelated RD index yielded more 
robust AD versus HD differences than the Total RD index, providing greater 
differentiation between individuals whose memory disorder is primarily at the 
encoding/storage level (e.g., AD) versus at the retrieval level (e.g., early HD). 
Relevance: Given the expanding older population and that memory loss is a hallmark 
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feature of cognitive impairment in both healthy aging and neurodegenerative disease, 
more refined memory indices are needed to elucidate the nature of memory changes that 
may be associated with normal aging and neurodegenerative processes. Collectively, 
Studies 1, 2, and 3 utilized innovative psychometric approaches with the CVLT-II to 
explore age-related differences on more nuanced aspects of yes/no recognition memory, 
as well as elucidate the extent of yes/no recognition memory impairment in AD and HD. 
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CHAPTER 1: 
Integrated Introduction 
The human life expectancy in the United States has continuously increased over 
the last several decades. Currently, age is the greatest known risk factor for 
neurodegenerative disease. Thus, as individuals live longer, their risk of developing 
dementia due to neurodegenerative disease is expected to increase. Alzheimer’s disease 
(AD) is the most common form of dementia, accounting for 60-80% of all cases 
(Alzheimer’s Association, 2016). In 2016, an estimated $236 billion was spent in the U.S. 
on care for individuals with AD. Costs are expected to rise to over $1.1 trillion by 2050 
unless fruitful efforts to identify and treat those with, or at risk for, AD are made. 
Huntington’s disease (HD), another form of dementia, is a debilitating neurodegenerative 
condition associated with a triad of motor, cognitive, and psychiatric symptoms. 
Although information available on the direct costs of HD is more limited, research has 
shown that annual costs of care increase with disease progression (Divino et al., 2013). 
Given that memory loss is a hallmark feature of cognitive decline in both healthy aging 
and dementia, more refined measures of memory are needed to further elucidate the 
nature of memory changes that may accompany normal aging and neurodegenerative 
disease. 
The California Verbal Learning Test (CVLT) is a standardized 
neuropsychological measure that provides a multitude of verbal learning and memory 
indices (Delis, Kramer, Kaplan, & Ober, 1987, 2000, 2017). The original and second 
editions of the CVLT have been widely used in research and clinical settings, to 
characterize memory function and decline in healthy aging as well as in various 
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neurodegenerative populations, including AD and HD. Recall, and to a lesser extent 
recognition memory, have been shown decline with age (Craik & McDowd, 1987; 
Danckert & Craik, 2013). Additionally, research has shown that the different patterns of 
neurodegeneration associated with AD and HD yield distinct profiles of memory loss 
(Delis et al., 1991; Hodges, Salmon, & Butters, 1990; Moss, Albert, Butters, & Payne, 
1986; Salmon & Bondi, 2009; Salmon & Filoteo, 2007; Troster et al., 1993). AD is 
associated with medial temporal lobe damage, particularly in the hippocampal formation, 
subsequent damage to cortical association areas, and relative sparing of most subcortical 
structures (Braak & Braak, 1991; Hyman, Van Hoesen, Damasio, & Barnes, 1984). 
Individuals with AD usually have pervasive memory deficits characterized by poor 
learning, rapid forgetting, and poor recognition (Budson & Kowall, 2013), a profile of 
memory loss thought to reflect an encoding/storage deficit. In contrast, HD is associated 
with early damage to basal ganglia structures (Vonsattel, 2000; Vonsattel et al., 1985) 
that have extensive projections to the frontal lobes (Alexander, Crutcher, & DeLong, 
1990; Crosson et al., 2003; Cummings, 1993), followed by more diffuse involvement of 
other cortical and subcortical regions and networks. Patients with early stage HD often 
have significant deficits in recall with less compromised recognition (Butters, Wolfe, 
Granholm, & Martone, 1986; Butters, Wolfe, Martone, Granholm, & Cermak, 1985; 
Lundervold, Reinvang, & Lundervold, 1994; Martone, Butters, Payne, Becker, & Sax, 
1984; Massman, Delis, Butters, Levin, & Salmon, 1990), a profile of memory loss 
thought to primarily reflect a retrieval deficit. Although recognition is less impaired than 
recall in early HD, recognition is often significantly impaired in the later stages of 
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disease, raising the possibility that encoding processes are also compromised to at least 
some degree (see Montoya et al., 2006 for review). 
Rationale for Study 1 
In general, studies using the original CVLT have shown that deficits in verbal 
learning and recall are less severe in HD than in AD (Delis et al., 1991; Kramer et al., 
1988; Kramer, Levin, Brandt, & Delis, 1989). Additionally, individuals with HD 
(particularly those in milder stages of the disease) have been shown to perform better 
than those with AD on the CVLT index of Recognition Discriminability (RD), which 
captures the ability to distinguish List A targets from all distractors on the Yes/No 
Recognition trial (Delis et al., 1991; Kramer et al., 1988). In particular, evidence suggests 
that better RD performance in HD relative to AD corresponds with lower false positive 
(FP) error rates in the former versus the latter (Kramer et al., 1988). 
Only one study prior to Study 1 of this staple dissertation project directly 
compared HD and AD performance on the CVLT-II Yes/No Recognition trial (Fine et 
al., 2008). The study found that individuals with HD performed significantly better than 
those with AD on CVLT-II measures of Total RD and Novel RD (which captures the 
ability to distinguish List A targets from novel distractors), but comparably on Source RD 
(which captures the ability to distinguish List A targets from List B distractors). Thus, 
studies using the CVLT and CVLT-II that were conducted prior to Study 1 collectively 
demonstrated that Total RD is less impaired in HD than in AD. 
The original and second editions of the CVLT utilized nonparametric and 
parametric formulas, respectively, to compute a Total Recognition Discriminability 
(Total RD) index, which assesses the ability to distinguish List A target items from all 
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distractor types on the Yes/No Recognition trial. Although CVLT and CVLT-II studies 
conducted prior to Study 1 demonstrated that Total RD performance is less impaired in 
HD than in AD (Delis et al., 1991; Fine et al., 2008; Kramer et al., 1988; Kramer, Levin, 
Brandt, & Delis, 1989), the degree to which AD and HD differences on Total RD may 
vary across applications of nonparametric and parametric methods for calculating Total 
RD had not been explored. Insight into whether such variation occurs would potentially 
inform efforts to interpret and compare CVLT and CVLT-II findings regarding yes/no 
recognition memory in HD and AD. Additionally, insight into whether the nonparametric 
and parametric formulas for Total RD differ in the extent to which they capture FP error 
rates would assist in elucidating the nature of yes/no recognition memory impairment in 
these populations. Moreover, limited evidence regarding HD performance on the CVLT-
II relative to a demographically similar comparison group was available prior to Study 1, 
and existing studies were based on relatively small samples. Accordingly, Study 1 of this 
staple dissertation project examined whether AD and HD differences on Total RD varied 
across applications of nonparametric (used in original CVLT) and parametric (used in 
CVLT-II) formulas for calculating Total RD in a relatively large sample of individuals 
with HD, individuals with AD, and two demographically similar healthy comparison 
groups (Graves et al., 2017). 
Rationale for Study 2 
Although not affected to the same degree as recall, recognition memory has been 
shown to decline with age (Craik & McDowd, 1987; Danckert & Craik, 2013). 
Accordingly, older adults have been shown to exhibit worse performance relative to 
young adults on CVLT indices of recall, and to a lesser extent, recognition (Delis et al., 
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1987; Ebert & Anderson, 2009; Kausler, 1994; Turner & Pinkston, 1993; Van der 
Linden, Philippot, & Heinen, 1997; Woodruff-Pak & Finkbiner, 1995). Moreover, studies 
have shown that the effect of aging is greater on source memory than on item memory 
(Bayer et al. 2011; Dennis et al., 2008; Glisky & Kong, 2008; Hashtroudi, Johnson, & 
Chrosniak, 1989; McIntyre & Craik, 1987; Naveh-Benjamin & Craik, 1995; Schacter, 
Kaszniak, Kihlstrom, & Valdiserri, 1991; Spaniol, Madden, & Voss, 2006; Trott, 
Friedman, Ritter, Fabiani, & Snodgrass, 1999). In addition to Total RD, the CVLT-II 
provides an index of Source RD, which assesses the ability to distinguish List A target 
items from List B distractor items on the CVLT-II Yes/No Recognition trial. Thus, the 
Source RD index, although not a direct measure of source memory per se, taps into 
aspects of source memory by measuring one’s ability to distinguish whether a word was 
included on List A or List B. The CVLT-II also includes an index of Novel RD, which 
assesses the ability to distinguish List A targets from novel distractors (i.e., items that 
were not previously presented during test administration prior to the Yes/No Recognition 
trial). Thus, the Novel RD index represents recognition memory in a more traditional 
sense, providing a measure of one’s ability to distinguish “old” stimuli (i.e., target items) 
from “new” stimuli (i.e., novel distractor items). Half of the List B distractors as well as 
novel distractors are prototypical, or semantically related to targets, rendering them 
perhaps more challenging to identify as distractors than the other half of the List B and 
novel distractors, which are semantically unrelated to targets (e.g., Baldo et al., 2002). 
Thus, more refined indices that isolate the ability to distinguish List A targets from 
semantically-unrelated List B and novel distractors may yield purer assessments of 
Source and Novel RD, respectively. 
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Study 2 of this staple dissertation project sought to examine between- and within-
group differences on the four false positive (FP) error subtypes found on the CVLT-II 
Yes/No Recognition trial (prototypical List B, unrelated List B, prototypical novel, and 
unrelated novel) in healthy older and young adults. Additionally, FP error rates were used 
to generate and compare d’ scores between healthy older and young adults on multiple 
variations of Source and Novel RD that differed in the degree of semantic association 
between targets and distractors. It was generally hypothesized that more refined Source 
and Novel RD indices, that minimized levels of semantic interference, would yield 
smaller age group differences on Yes/No Recognition testing, thereby elucidating the 
nature or degree of age-related differences on more nuanced aspects of yes/no recognition 
memory. 
Rationale for Study 3 
Studies using the original CVLT consistently demonstrated that deficits on the 
Yes/No Recognition trial are less severe in mildly demented individuals with HD than in 
equally demented individuals with AD (Delis et al., 1991; Kramer et al., 1988; Kramer, 
Levin, Brandt, & Delis, 1989). This difference was shown with the original CVLT Total 
RD index that measures the ability to distinguish List A targets from all distractors on the 
Yes/No Recognition trial (Delis et al., 1991; Kramer et al., 1988). In contrast, studies that 
compared individuals with AD and those with HD on the CVLT-II Yes/No Recognition 
trial have produced inconsistent results. While one study found that individuals with HD 
obtained higher standardized scores than those with AD on the CVLT-II Total RD index 
(Fine et al., 2008), another study with a larger sample found that AD and HD groups 
performed comparably on this measure (Study 1; Graves et al., 2017). One implication of 
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this pattern of results is that individuals with HD may have worse Yes/No Recognition 
performance on the CVLT-II than on the original CVLT. This possibility is consistent 
with the clinical observation that Total RD scores of patients with HD are generally lower 
on the CVLT-II than on the original CVLT (Dean C. Delis, personal communication, 
October 26, 2017). 
Reasons for differences in the performance of individuals with HD on the Yes/No 
Recognition trials of the two versions of the CVLT may lie in differences in how Total 
RD is calculated. The Yes/No Recognition trial on the original CVLT included only half 
(i.e., eight) of the 16 List B items as distractors (Delis et al., 1987). Due to a ceiling effect 
in cognitively normal individuals, the difficulty of the trial was increased on the CVLT-II 
by including all 16 List B items as distractors (Dean C. Delis, personal communication, 
September 26, 2017). Although this had the intended effect of making the Yes/No 
Recognition trial more difficult, it potentially made the test more sensitive to deficits in 
source memory. Individuals with frontal-system dysfunction (e.g., HD) may have 
particular difficulty in identifying the source of each previously-presented item (List A or 
List B) during the Yes/No Recognition trial when asked whether or not an item had been 
on List A (Fine et al., 2008), and increasing the number of List B distractors on the 
CVLT-II Yes/No Recognition trial may have amplified this difficulty. 
The CVLT-II Yes/No Recognition trial also had an increased proportion of 
distractors that are semantically related to List A target items (eight of 28 distractors for 
the CVLT versus 16 of 32 distractors for the CVLT-II). Research has shown that patients 
with frontal-system dysfunction are prone to making semantic intrusion or semantic 
confusion errors due to impaired inhibition of activation within semantic networks (e.g., 
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Baldo et al., 2002). A deficit in inhibition of the semantic network during the CVLT may 
lead individuals with HD to have greater difficulty in rejecting distractors that share 
obvious semantic associations with targets than in rejecting distractors that do not (the 
same deficit could lead to semantically-related intrusion errors during free recall trials). 
This would have a greater adverse effect on the CVLT-II than the CVLT for individuals 
with HD due to the increased proportion of semantically-related distractors. Increasing 
the proportion of semantically-related distractors may not have the same effect on 
individuals with AD since their severe recognition memory deficits reflect a profound 
encoding/storage deficit that can be attributed to more extensive neuropathology targeting 
the medial temporal lobes and cortical association areas. Thus, individuals with AD are 
likely to exhibit relatively comparable levels of difficulty in rejecting novel distractors 
whether or not they share obvious semantic associations with targets. 
While the CVLT-II included eight novel unrelated distractor items on the Yes/No 
Recognition trial, it did not provide a separate index that assessed the ability of 
individuals to endorse List A targets while rejecting those novel unrelated distractors. 
The second and third editions of the CVLT (CVLT-II and CVLT-3, respectively) contain 
the same target words on the recall trials and the same targets and distractors on the 
Yes/No Recognition trial (in fact, the only word-item changes that were made to the 
CVLT-3 are on the Forced Choice Recognition trial). However, the CVLT-3 (Delis, 
Kramer, Kaplan, & Ober, 2017) includes a more refined RD index, List A vs. 
Novel/Unrelated RD, that isolates the ability to distinguish List A targets from distractors 
that were not previously presented during test administration and do not share obvious 
semantic associations with targets. Thus, the new List A vs. Novel/Unrelated RD index 
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minimizes any potential influences of source and semantic interference, and is therefore 
thought to provide a purer assessment of yes/no recognition memory. 
Study 3 of this staple dissertation project sought to elucidate the nature and extent 
of AD and HD differences in yes/no recognition memory by examining performance in 
individuals with AD and HD on CVLT-3 indices of Total RD and List A vs. 
Novel/Unrelated RD. It was hypothesized that although both AD and HD would be 
associated with deficits on Yes/No Recognition testing, individuals with HD would 
perform better than those with AD, particularly on the new List A vs. Novel/Unrelated 
RD index. In other words, the List A vs. Novel/Unrelated RD index, in minimizing any 
potential influences of source and semantic interference, was expected to yield a purer 
assessment of yes/no recognition memory in HD and thereby exhibit greater 
differentiation than the Total RD index between individuals with HD and those with AD. 
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CHAPTER 2:  
Study 1 
The content within this section, titled “Chapter 2: Study 1,” reflects material from 
a paper that has been published in the Journal of Clinical and Experimental 
Neuropsychology. The proper citation is as follows: 
 
Graves, L. V., Holden, H. M., Delano-Wood, L., Bondi, M. W., Woods, S. P., Corey-
Bloom, J., Salmon, D. P., Delis, D. C., & Gilbert, P. E. (2017). Total recognition 
discriminability in Huntington’s and Alzheimer’s disease. Journal of Clinical and 
Experimental Neuropsychology, 39(2), 120-130. doi:10.1080/13803395.2016.1204993 
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Abstract 
Both the original and second editions of the California Verbal Learning Test 
(CVLT) provide an index of total recognition discriminability (TRD) but respectively 
utilize nonparametric and parametric formulas to compute the index. However, the 
degree to which population differences in TRD may vary across applications of these 
nonparametric and parametric formulas has not been explored. We evaluated individuals 
with Huntington’s disease (HD), individuals with Alzheimer’s disease (AD), healthy 
middle-aged adults, and healthy older adults who were administered the CVLT-II. Yes/no 
recognition memory indices were generated, including raw nonparametric TRD scores 
(as used in CVLT-I) and raw and standardized parametric TRD scores (as used in CVLT-
II), as well as false positive (FP) rates. Overall, the patient groups had significantly lower 
TRD scores than their comparison groups. The application of nonparametric and 
parametric formulas resulted in comparable effect sizes for all group comparisons on raw 
TRD scores. Relative to the HD group, the AD group showed comparable standardized 
parametric TRD scores (despite lower raw nonparametric and parametric TRD scores), 
whereas the previous CVLT literature has shown that standardized TRD scores are lower 
in AD than in HD. Possible explanations for the similarity in standardized parametric 
TRD scores in the HD and AD groups in the present study are discussed, with an 
emphasis on the importance of evaluating TRD scores in the context of other indices such 
as FP rates in an effort to fully capture recognition memory function using the CVLT-II. 
 
Keywords: California Verbal Learning Test, California Verbal Learning Test – Second 
Edition, recognition discriminability, Huntington’s disease, Alzheimer’s disease   
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Total Recognition Discriminability in Huntington’s and Alzheimer’s Disease 
The California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 
1987, 2000) is a standardized neuropsychological test that provides a multitude of verbal 
learning and memory indices. The original and second editions of the CVLT (CVLT-I 
and CVLT-II, respectively) are widely used in research and clinical settings and have 
been utilized in efforts to characterize memory function and decline in various 
populations. 
Total Recognition Discriminability (TRD) on the CVLT 
Both versions of the CVLT include a TRD index, which is a single score that 
reflects the ability of the examinee to endorse target items and reject distractor items. The 
CVLT-I used the following nonparametric formula (see Underwood, 1974) to compute a 
TRD index that was interpreted as a percentage, with 100 (%) set as the maximum 
possible score: 
TRDCVLT-I,nonp = [1 – (total FPs + total misses) / 44] x 100. 
Thus, the nonparametric TRD index incorporates an examinee’s total number of FPs into 
a ratio or percentage TRD score. In addition to differentiating patient and control 
populations, this index has been useful in distinguishing patients with different profiles of 
memory loss, particularly those with primarily cortical (e.g., AD) versus subcortical (e.g., 
HD) degeneration (see Delis et al., 2000 for review). 
The CVLT-I was developed between 1979 to 1981, prior to the availability of 
personal computers. As was discussed in the CVLT-II manual (Delis et al., 2000), the 
nonparametric measure of TRD was employed in the CVLT-I because it allowed for a 
relatively quick, convenient calculation of recognition discriminability by hand and still 
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correlated strongly with more complex parametric signal-detection measures such as d’. 
However, as noted by Corwin (1994), the nonparametric formula was less able than other 
measures to account for response bias on recognition memory tasks with an unequal 
number of target and distractor items, such as the yes/no recognition memory task on the 
CVLT-II. Alternatively, d’ is calculated independently of response bias, rendering it 
better suited for tests with an unequal number of target and distractor items. By the time 
the CVLT-II was developed, personal computers were widely available and facilitated the 
efficient application of more complex mathematical methods for assessing recognition 
memory function, further strengthening the rationale for employing the parametric d’ 
measure to compute the TRD index on the CVLT-II. 
A raw d’ score reflects the absolute difference in standard deviation units between 
an examinee’s hit rate and FP rate and is therefore analogous to a contrast z score (Delis 
et al., 2000; Macmillan & Creelman, 1991): 
TRDCVLT-II,d’ = z(hit rate) – z(FP rate). 
Thus, in contrast to the nonparametric TRD score, which more generally reflects an 
examinee’s percentage of correct responses, the parametric TRD score more specifically 
reflects an examinee’s hit rate relative to their FP rate. In this regard, the parametric 
formula for TRD might better capture recognition memory function in cases where there 
are unequal numbers of target and distractor items. However, whether the parametric 
formula for TRD sufficiently captures the full magnitude of FP errors, particularly in 
individuals who are susceptible to committing very high FP rates (e.g., those with AD) is 
not entirely clear and warrants further consideration. Additional distractor items were 
included on the CVLT-II relative to the CVLT-I to increase test difficulty and lower the 
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ceiling effect that is often found on recognition memory tests, including that on the 
CVLT-I (Dean C. Delis, personal communication, December 5, 2015). Specifically, the 
CVLT-II includes all 16 List B distractor items, whereas the CVLT-I included only 8 List 
B distractor items. Thus, the proportion of distractor items that are from List B is larger 
on the CVLT-II (16/32) than on the CVLT-I (8/28). In shifting from the use of a 
nonparametric TRD formula in the CVLT-I to the use of a parametric TRD formula in 
the CVLT-II, it is unclear whether an attempt to accommodate the imbalance between the 
number of target and distractor items on the yes/no recognition memory test comes at the 
cost of not fully capturing the true possible range of FP rates that may occur in certain 
neurodegenerative populations. 
HD, AD, and Profiles of Memory Loss 
HD is a neurodegenerative disorder caused by expanded repetitions of the 
cytosine-adenine-guanine (CAG) trinucleotide on the huntingtin gene located on the short 
arm of chromosome 4 (Huntington’s Disease Collaborative Research Group, 1993). HD 
is characterized by an array of motor, cognitive, and psychiatric changes. Motor changes 
include chorea in addition to bradykinesia, rigidity, and ataxia (Ross et al., 2014). 
Cognitive deficits associated with HD include impaired episodic memory, executive 
functioning, attention, and visuospatial processing (Dumas, van den Bogaard, 
Middelkoop, & Roos, 2013). On the other hand, AD is characterized by early deficits in 
episodic memory followed by later decline in other cognitive domains including 
language, executive functioning, and visuospatial processing (Salmon & Bondi, 2009). In 
contrast to HD, motor functioning is relatively preserved in the context of AD. 
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The classic profile of episodic memory loss in AD is thought to be one of poor 
encoding and retention of information, which lead to rapid forgetting and result in 
impaired recall and recognition (Budson & Kowall, 2013; Dickerson & Atri, 2014; 
Salmon & Bondi, 2009). Conversely, earlier evidence suggests that individuals with HD 
exhibit what has been referred to as a “subcortical profile” of episodic memory decline 
that includes poor recall and improvements in recognition. This profile is thought to 
reflect impaired retrieval processes but relatively intact encoding and maintenance 
mechanisms and is particularly evident in earlier stages of the disease (Butters, Wolfe, 
Martone, Granholm, & Cermak, 1985; Butters, Delis, & Lucas, 1995; Delis et al., 1991). 
More recent evidence suggests that recognition memory is indeed compromised in HD, 
but to a lesser extent than recall (see Montoya et al., 2006 for review). Indeed, the extant 
literature strongly suggests that, although individuals with HD and AD have both been 
shown to exhibit recall deficits, recognition memory is thought to be less impaired in HD, 
at least in the earlier stages of the disease. 
Studies using the CVLT-I and CVLT-II have generally shown that individuals 
with HD and AD are impaired in various aspects of verbal learning and memory, and that 
they differ from other populations (both healthy and impaired) and from each other in 
their profiles of memory loss (see Elwood, 1995 for review of CVLT-I literature). 
HD and AD performance on the CVLT. Research suggests that individuals with 
HD perform worse than a demographically similar comparison group on multiple 
measures of verbal learning and recall on the CVLT-I (Kramer et al., 1988; Massman, 
Delis, Butters, Levin, & Salmon, 1990; Massman, Delis, Butters, Dupont, & Gillin, 1992; 
Massman, Delis, & Butters, 1993). Some studies have shown that those with HD 
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demonstrate worse recognition discriminability (Kramer et al., 1988; Lundervold, 
Reinvang, & Lundervold, 1994; Massman et al., 1990), and other evidence suggests that 
they exhibit greater improvement on recognition discriminability relative to Trial 5 recall 
(Massman et al., 1992). Various studies also have indicated that individuals with AD 
perform worse than healthy older adults on multiple indices of verbal learning and recall 
on the CVLT-I (Delis et al., 1991; Deweer et al., 1994; Kramer et al., 1988; Massman et 
al., 1993; Mendez & Ashla-Mendez, 1991; Simon, Leach, Winocur, & Moscovitch, 
1994). Additionally, those with AD have been shown to demonstrate higher FP rates or a 
positive response bias (Delis et al., 1991; Deweer et al., 1994; Kramer et al., 1988), worse 
recognition discriminability (Delis et al., 1991; Deweer et al., 1994; Kramer et al., 1988), 
and no improvement on recognition testing relative to free recall (Delis et al., 1991). 
No prior studies to the authors’ knowledge have examined CVLT-II performance 
in individuals with HD relative to a demographically similar comparison group (i.e., 
cognitively healthy middle-aged adults). One study investigated the effects of 
rivastigmine treatment on cognitive function in early stage HD and included a group of 
healthy controls to account for practice effects between baseline and follow-up 
assessments (Sesok, Bolle, Kobal, Bucik, & Vodusek, 2014). However, no direct 
comparisons between patients and controls in performance on neuropsychological 
measures (including the CVLT-II) were made. Consistent with CVLT-I findings, studies 
using the CVLT-II have shown that individuals with AD perform worse than healthy 
older adults on most measures of recall (Delis et al., 2005; Duarte et al., 2006; Sherod et 
al., 2009) as well as recognition discriminability (Duarte et al., 2006). 
HD/AD comparisons on the CVLT. In general, studies using the CVLT-I have 
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shown that deficits in verbal learning and recall are less severe in individuals with HD 
relative to those with AD (Delis et al., 1991; Kramer et al., 1988; Kramer, Levin, Brandt, 
& Delis, 1989). Additionally, evidence suggests that individuals with HD – particularly 
in milder stages of the disease – demonstrate better recognition discriminability than 
those with AD on the CVLT-I (Delis et al., 1991; Kramer et al., 1988) that is reflected by 
lower FP rates in the absence of differences in hit rates (Kramer et al., 1988). Also, 
compared to individuals with AD, those with HD have shown greater improvement on 
recognition discriminability relative to Trial 5 recall (Delis et al., 1991). Some evidence 
suggests that individuals with mild HD have a smaller positive response bias than those 
with AD on the CVLT-I (Kramer et al., 1988), whereas other findings have not found 
such group differences (Delis et al., 1991). 
Only two studies have examined the relative performance of individuals with HD 
and AD on the CVLT-II. The first study revealed that whereas those with HD and AD do 
not differ on immediate and delayed recall measures when using the traditional measure 
of target recall, those with AD perform significantly worse than those with HD on short-
delay free recall, short-delay cued recall, and long-delay cued recall when using a new 
index called “recall discriminability” that analyzes target recall relative to intrusion rate 
(Delis et al., 2005). The second study revealed that those with AD perform significantly 
worse than those with HD on CVLT-II measures of total and novel recognition 
discriminability, but comparably on measures of source recognition discriminability (Fine 
et al., 2008). These studies were based on the same sample of 16 individuals with HD and 
17 individuals with AD. 
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Although the two versions of the CVLT utilize different formulas to compute the 
TRD index, no prior study has directly assessed the degree to which population 
differences in TRD vary across applications of these nonparametric and parametric 
methods. Insight into whether or not such variation occurs would inform efforts to 
interpret and compare CVLT-I and CVLT-II findings regarding recognition memory 
function in HD and AD in particular. Additionally, insight into whether the 
nonparametric and parametric formulas for TRD differ in the extent to which they 
capture FP errors would be helpful in improving efforts to accurately characterize 
recognition memory function in these populations in research and clinical settings. 
Moreover, limited evidence exists regarding HD performance relative to a 
demographically similar comparison group on the CVLT-II, and what is available is 
based on relatively small samples. Therefore, the purpose of the present study was to 
compare nonparametric and parametric assessments of TRD using the CVLT-II in a 
relatively large sample of individuals with HD and AD and two demographically similar 
comparison groups. 
Method 
Participants 
Participants included 66 individuals with HD, 33 individuals with AD, 68 healthy 
middle-aged adults (comparison sample for the HD group), and 35 healthy older adults 
(comparison sample for the AD group). Individuals with HD were recruited from the 
Huntington’s Disease Clinical Research Program (HDCRP) at the University of 
California, San Diego (UCSD), which follows a cohort of individuals with HD who have 
participated in longitudinal clinical studies and undergone annual evaluations of cognitive 
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and motor symptoms (a portion of the HD group came from the same sample used in the 
studies by Delis et al., 2005 and Fine et al., 2008). The HD group was administered the 
Unified Huntington’s Disease Rating Scale (UHDRS; Huntington Study Group, 1996) by 
a senior staff neurologist at the HDCRP. Individuals with HD were diagnosed with 
definite HD on the basis of unequivocal motor signs on the UHDRS and a positive family 
history of HD. In addition, all HD participants had a CAG repeat length greater than 39, 
indicating that all carried the fully penetrant genetic mutation for HD. Exclusionary 
criteria for individuals with HD and healthy middle-aged adults included the following: a 
diagnosis of any neurological disorder (with the exception of HD in the HD group), a 
diagnosis of any major medical condition (e.g., cancer), a diagnosis of any psychiatric 
disorder (with the exception of a mood or anxiety disorder in the HD group, for which 
any current symptoms were managed with medication), a history of traumatic brain 
injury, and a history of substance abuse. All participants provided informed written 
consent and this portion of the study was approved by the Institutional Review Boards of 
San Diego State University (SDSU) and UCSD. 
CVLT-II data from the 33 individuals with AD and 35 healthy older adults were 
extracted from an archival database that included data from a larger battery of 
neuropsychological tests administered at the Shiley-Marcos Alzheimer’s Disease 
Research Center (ADRC) in La Jolla or the Veterans Affairs San Diego Healthcare 
System (VASDHS) (a portion of the AD group came from the same sample used in the 
studies by Delis et al., 2005 and Fine et al., 2008). Participants at both sites were 
administered a standardized battery of tests by trained research assistants or 
psychometrists. Diagnoses of individuals with probable AD were consistent with the 
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criteria established by the National Institute of Neurological and Communicative 
Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association (ADRDA) 
workgroup (McKhann et al., 1984; McKhann et al., 2011). 
Healthy middle-aged and older adults were recruited from the San Diego 
community by the HIV Neurobehavioral Research Center (HNRC) and the Bondi 
Laboratory at UCSD, respectively, using flyers (posted with approval by public 
sites/institutions) and outreach to senior centers. Efforts were made to target healthy 
populations with demographic characteristics similar to those of the patient groups. 
Measures 
Dementia Rating Scale-2 (DRS-2). Individuals with HD and AD completed the 
DRS-2 (Jurica, Leitten, & Mattis, 2001), a measure of global cognitive functioning, as 
part of a larger neuropsychological battery. 
CVLT-II and TRD indices. The CVLT-II was administered as part of a larger 
neuropsychological battery to all participants using standard administration procedures 
outlined by Delis and colleagues (Delis et al., 2000). CVLT-II data were collected 
between May 2002 and July 2013. The CVLT-II involves the presentation of word-lists 
and provides a multitude of verbal learning and memory indices, including immediate 
recall, free and cued recall over short and long delays, and recognition memory. The 
TRD indices that were of primary interest to the present study were derived from the 
yes/no recognition memory portion of the CVLT-II. In the present study, short- and long-
delay tests of recall were separated by an interval of approximately 20 minutes, during 
which other nonverbal neuropsychological measures were administered. CVLT-II data 
were scored using CVLT-II scoring software (Delis & Fridlund, 2000). 
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Nonparametric and parametric TRD scores were calculated using CVLT-II data. 
Raw nonparametric TRD scores were computed using the following formula: 
TRDCVLT-II,nonp = [1 – (total FPs + total misses) / 48] x 100. 
Note that the CVLT-II contains 48 total items in the yes/no recognition memory test, 
whereas the CVLT-I contained 44 items. Raw and standardized parametric TRD scores 
were computed by CVLT-II software. Raw nonparametric and parametric TRD scores in 
addition to standardized parametric TRD scores were analyzed. An analysis of 
standardized nonparametric TRD scores could not be conducted, as the normative data 
that would be required to do so have not been published or made available otherwise. 
Statistical Analyses 
Analyses were conducted in Statistical Package for the Social Sciences (SPSS) 
Version 22. Prior to examining group differences in TRD scores, chi-square analyses 
were conducted to determine whether groups differed in gender. In addition, analysis of 
variance (ANOVA) tests were conducted to determine whether groups differed in age, 
education, or DRS-2 scores. 
Shapiro-Wilk tests of normality revealed that TRD scores were non-normally 
distributed in the present sample (p < .05). Therefore, Mann-Whitney U tests were 
conducted to examine differences in raw nonparametric and parametric TRD scores in the 
comparison of the HD group to healthy middle-aged adults and in the comparison of the 
AD group to healthy older adults. For the HD and AD group comparisons on raw 
nonparametric and parametric TRD scores, nonparametric and parametric TRD scores 
were ranked, and two-way ANOVA tests were conducted to examine group differences 
in the ranked TRD scores, while including gender as a second between-subjects factor 
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(Akritas, 1990; Baguley, 2012). Mann-Whitney U tests were conducted to examine group 
differences in standardized parametric TRD scores in all comparisons of interest. 
Effect size values for each group comparison in each analysis of TRD scores were 
calculated. Following Mann-Whitney U tests, r values for the group effect were 
computed by dividing the Z value associated with the U statistic by the square root of N 
(Fritz, Morris, & Richler, 2012). Following two-way ANOVA tests on ranked data, r 
values for the group effect were computed manually using sum of squares (SS) error 
terms from the SPSS output and the following formula: reffect = (SSeffect /SStotal). All r 
values were converted to Cohen’s d effect size estimates using the following formula: d = 
2r/(1-r2). Fisher’s r to z transformation analyses were conducted to determine whether 
group differences in TRD scores significantly differed between applications of 
nonparametric and parametric methods. Spearman rank correlation analyses and Fisher’s 
r to z transformation analyses also were conducted in a set of exploratory analyses 
involving FP rates, TRD scores, and source recognition discriminability (SoRD; the 
endorsement of List A target items and rejection of List B distractor items) scores. 
Although a comparison of standardized nonparametric and parametric TRD 
scores could not be made, standardized parametric TRD scores were still analyzed to 
provide researchers and clinicians with the opportunity to make relevant inferences with 
the present data, as the norms for standardized TRD scores are available in the CVLT-II 
manual and are widely utilized in research and clinical settings. 
Results 
Demographic information for the HD and AD groups and their respective 
comparison groups is provided in Table 2.1. A chi-square analysis revealed that there 
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were no differences in the percentage of men versus women between the HD group and 
healthy middle-aged adults or between the AD group and healthy older adults (ps > .05). 
However, compared to the HD group, the AD group had a significantly greater 
percentage of men relative to women, χ2 (N = 91) = 9.06, p < .01. Thus, subsequent 
analyses examining differences in raw nonparametric and parametric TRD scores 
between the HD and AD groups included gender as a between-subjects factor. 
A one-way ANOVA test revealed that there were no differences in age between 
the HD group and healthy middle-aged adults or between the AD group and healthy older 
adults (ps > .05).  However, individuals with AD were significantly older than those with 
HD, t(89) = 14.15, p < .001, which was expected given known differences in the age of 
disease onset. This highlights that age is systematically confounded with group in the 
comparison of HD and AD, which renders including age as a covariate in subsequent 
analyses examining differences in raw TRD scores between the HD and AD groups a 
statistically invalid method for parceling out age effects on raw TRD scores. This issue is 
inherently present in studies involving the comparison of raw scores between groups of 
individuals with HD and AD. Accordingly, age was not included as a factor in ANOVA 
tests examining differences in raw TRD scores between the HD and AD groups in the 
present study. Moreover, the size of the present sample would not accommodate 
alternative analyses that might otherwise address this issue. 
A one-way ANOVA test revealed no differences in education between the HD 
and AD groups; the HD group and healthy middle-aged adults; or the AD group and 
healthy older adults (ps > .05).  The HD and AD groups did not differ in mean DRS-2 
scores (p > .05), suggesting that the groups were comparable in terms of overall cognitive 
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impairment. Moreover, the variation in DRS-2 scores within each of the patient groups 
was minimal. 
As shown in Table 2.2, Mann-Whitney U tests revealed that the HD and AD 
groups performed significantly worse than their respective comparison groups on all 
TRD indices. According to Fisher’s r to z transformation analyses, the effect sizes 
associated with the nonparametric and parametric formulas were comparable in all 
comparisons of patient groups to their respective comparison groups (ps > .05; see Table 
2.3). 
As shown in Table 2.2, ANOVA tests on ranked data revealed that the AD group 
performed significantly worse than the HD group on raw nonparametric and parametric 
TRD indices. In the comparison of the HD and AD groups using raw scores, the 
difference in effect sizes associated with the nonparametric and parametric formulas was 
negligible and was not statistically significant according to a Fisher’s r to z 
transformation analysis (p > .05; see Table 2.3). However, a Mann-Whitney U test 
revealed that the AD group performed comparably to the HD group on standardized 
parametric TRD, despite the observation that the AD group had significantly lower raw 
parametric TRD scores than the HD group. Table 2.2 displays the inferential and 
descriptive statistics for all planned group comparisons on TRD scores. 
Exploratory analyses were conducted in an attempt to elucidate the observation 
that the AD group had standardized parametric TRD scores that were comparable to 
those in the HD group, despite lower raw nonparametric and parametric TRD scores. 
Specifically, additional analyses involving FP rates, TRD scores, and SoRD scores were 
conducted. 
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Mann-Whitney U tests were conducted to examine differences between the HD 
and AD groups in raw and standardized FP rates. The Mann-Whitney U tests revealed 
that the AD group (MdnFPraw = 14.00; MdnFPz = 2.50) had significantly higher raw, U = 
339.50, p < .001, and standardized FP rates, U = 611.50, p < .01, than the HD group 
(MdnFPraw = 5.00; MdnFPz = 1.00). Spearman rank correlation analyses then were 
conducted to examine correlations between raw FP rates and raw nonparametric and 
parametric TRD scores in the HD and AD groups. The analyses revealed significant 
negative correlations between raw FP rates and raw nonparametric and parametric TRD 
scores in the HD (rs_FP(nonp) = -.73, p < .001; rs_FP(d’) = -.57, p < .001) and AD (rs_FP(nonp) 
= -.91, p < .001; rs_FP(d’) = -.64, p < .001) groups. Moreover, Fisher’s r to z 
transformation analyses revealed that the correlation between raw FP rates and raw 
nonparametric TRD scores was significantly larger than the correlation between raw FP 
rates and raw parametric TRD scores in the AD group (z = 2.99, p < .01) but not the HD 
group (z = 1.46, p = .14). However, it is important to note that because FP errors are 
incorporated in the calculation of the TRD index, the reported correlations between FP 
rates and TRD scores may be influenced by a certain degree of circularity. 
Additionally, exploratory analyses were conducted to examine differences 
between the HD and AD groups in SoRD scores. A Mann-Whitney U test revealed that 
the AD group (Mdn = 0.80) had significantly lower raw SoRD scores than the HD group 
(Mdn = 1.75), U = 370.50, p < .001. However, the HD (Mdn = -1.50) and AD (Mdn = -
2.00) groups were comparable on standardized SoRD scores, U = 874.50, p = .49. 
Discussion 
 26 
In the present study, nonparametric and parametric formulas were applied in the 
assessment of TRD using the CVLT-II in a relatively large sample of individuals with 
HD and AD and healthy adults. As expected, the HD and AD groups performed worse 
than their respective comparison groups on nonparametric (raw) and parametric (raw and 
standardized) indices of TRD. It is worth noting that the effect size for the comparison of 
AD and healthy older adults on standardized parametric TRD scores was larger than the 
effect size for the HD and healthy middle-aged adults comparison. However, this 
difference is consistent with empirical evidence suggesting that individuals with HD 
exhibit rather heterogeneous cognitive abilities, with memory deficits that are typically 
less severe than those observed in individuals with AD. 
Relative to the HD group, the AD group had comparable standardized parametric 
TRD scores despite lower raw nonparametric and parametric TRD scores (even after 
adjusting for gender, which is corrected for in the standardization of scores on the CVLT-
II). The examination of raw scores in research may be informative, yet clinical judgments 
about the nature of recognition memory abilities and dysfunction by default rely on the 
analysis and interpretation of standardized scores, as did previous efforts to characterize 
and distinguish profiles of memory loss in neurodegenerative populations using the 
CVLT. Interpreting standardized TRD scores from the present study in isolation would 
lead to the conclusion that individuals with AD show comparable deficits in TRD relative 
to those with HD. This is in contrast with findings from previous studies in which the 
CVLT-I (which employs the nonparametric formula) was used to assess TRD. These 
studies showed that individuals with AD exhibited worse recognition discriminability 
than those with HD (Delis et al., 1991; Kramer et al., 1988). Additionally, Fine et al. 
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(2008) used the CVLT-II to assess TRD in individuals with HD and AD and also found 
that those with AD performed worse than those with HD based on standardized scores, 
albeit using a smaller sample than the present study sample. 
A possible explanation for the similarity in standardized parametric TRD scores 
in the HD and AD groups in the present study, despite earlier evidence for individuals 
with AD performing worse than those with HD on standardized TRD scores using the 
CVLT, may involve the extent to which the nonparametric and parametric formulas for 
TRD capture high FP rates. Namely, the unequal number of target and distractor items on 
the CVLT-II (although better accounted for by the use of the parametric d’ formula to 
calculate the TRD index) may be an important factor to consider when assessing TRD in 
individuals with a tendency to commit high FP rates, such as individuals with AD. 
Consistent with previous findings (Kramer et al., 1988), the AD group in the present 
study committed significantly more FP errors than the HD group. In addition, exploratory 
analyses revealed significant negative correlations between raw FP rates and raw 
nonparametric and parametric TRD scores in both the HD and AD groups. Moreover, 
Fisher’s r to z transformation analyses revealed that the correlation between raw FP rates 
and raw nonparametric TRD scores was significantly larger than the correlation between 
raw FP rates and raw parametric TRD scores in the AD group but not the HD group. 
These observations highlight that the nonparametric TRD formula may more fully 
capture the contribution of FP errors to a TRD score and, as a result, provide important 
information regarding an examinee’s recognition memory function that may otherwise be 
lost in the application of the parametric TRD formula and the standardization of 
parametric TRD scores. The present data and findings suggest that TRD scores may be 
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somewhat overestimated (i.e., the impact of FP errors on TRD scores may be 
inadvertently reduced) in individuals with AD, leading them to appear to perform 
comparably to individuals with HD. However, as previously noted, it is important to note 
that because FP errors are incorporated in the calculation of the TRD index, the reported 
correlations between FP rates and TRD scores may be influenced by a certain degree of 
circularity. This point should be taken into consideration when interpreting the present 
findings. 
Another potentially important factor when considering the similarity in 
standardized parametric TRD scores in the HD and AD groups in the present study 
involves the greater number of List B distractor items included in the yes/no recognition 
memory test on the CVLT-II relative to the CVLT-I. Research has shown that individuals 
with HD and other individuals with frontal system pathology are susceptible to source 
memory deficits (Baldo et al., 2002; Fine et al., 2008; Pirogovsky et al., 2007). On the 
CVLT, these deficits may manifest in the endorsement of List B distractor items on the 
yes/no recognition memory test in particular (see Fine et al., 2008). Consequently, it may 
be argued that individuals with HD (including those in the present study) are likely to 
exhibit lower TRD scores on the CVLT-II than they would on the CVLT-I given the 
opportunity to endorse more List B distractor items on the CVLT-II, which could 
potentially result in comparable TRD scores to individuals with AD. However, an 
exploratory analysis of SoRD scores (i.e., the ability to endorse List A target items and 
reject List B distractor items) in the present study revealed that although the AD group 
had significantly lower raw SoRD scores than the HD group, the groups were comparable 
on standardized SoRD scores, which is consistent with previous findings (Fine et al., 
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2008). This suggests that the discrepancy between the present findings and those reported 
in previous CVLT studies regarding standardized parametric TRD scores in HD and AD 
is not likely due to differences in the number of List B distractor items included in the 
yes/no recognition memory test across the two versions of the CVLT. 
Taken together, the primary and exploratory findings of the present study 
highlight the importance and utility of examining nonparametric TRD scores and other 
recognition memory indices (e.g., FP rates) in addition to (not instead of) standardized 
parametric TRD scores when using the CVLT-II to characterize recognition memory 
function. 
Limitations 
There are some limitations to the present study that deserve acknowledgement 
and discussion. First, age was systematically confounded with group in the comparison of 
HD and AD. The mean ages of the two patient groups differed by more than three 
standard deviations. This rendered including age as a covariate an insufficient method for 
parceling out the effects of age on raw TRD scores in subsequent analyses examining 
differences in raw TRD scores between the HD and AD groups. Age was therefore not 
included in ANOVA tests examining differences in raw TRD scores between the HD and 
AD groups. Moreover, the size of the present sample would not accommodate alternative 
analyses that might otherwise address this issue. Although this limits the interpretation of 
direct comparisons between the HD and AD groups, it reflects an inherent issue in studies 
involving the comparison of raw scores between individuals with HD and AD because of 
the known difference in the average age of disease onset. In light of the issue, it is 
important to emphasize that the HD and AD groups were equivalent in terms of overall 
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cognitive impairment based on DRS-2 scores, which are commonly used in 
neuropsychological studies to evaluate and compare the severity of disease in 
neurological populations. Second, CVLT-II data were collected between May 2002 and 
July 2013, and individuals were diagnosed with probable AD in alignment with the 
criteria established by the National Institute of Neurological and Communicative 
Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association (ADRDA) 
workgroup (McKhann et al., 1984; McKhann et al., 2011). More specifically, some 
individuals were diagnosed with AD using the criteria established in 1984, while other 
individuals were diagnosed with AD using the criteria that were updated in 2011. 
Although the general framework of probable AD dementia from the 1984 criteria were 
retained in the 2011 criteria, the 2011 criteria emphasize documenting cognitive decline 
in persons who meet the core clinical criteria for probable AD dementia to increase the 
certainty of diagnosis. We believe it is important to acknowledge that the present study 
sample consists of individuals with AD who were diagnosed using either the 1984 or 
2011 criteria, and to encourage readers to take this into consideration in the evaluation of 
the present findings. Third, the size of the AD group in the present study was relatively 
small compared to the HD group. However, compared to previously published studies 
involving the CVLT-II, the AD group in the present study was substantially larger. 
Fourth, the study sample was relatively well educated and may not fully represent the 
population. However, it could be hypothesized that the observed magnitude of deficits in 
TRD in the patient groups actually may be increased in a sample of individuals with less 
cognitive reserve. Finally, we would like to acknowledge that although it would have 
been helpful to include an analysis and discussion of performance validity data derived 
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from the forced-choice recognition test, these data are not available for all participants in 
the study sample. 
Conclusion 
The present study found that, relative to individuals with HD, individuals with 
AD had comparable standardized parametric TRD scores despite lower raw 
nonparametric and parametric TRD scores, which is in contrast with what has been 
previously reported in the CVLT literature. A possible explanation for this difference in 
findings between the present and previous studies involves potential differences in the 
extent to which the nonparametric and parametric formulas for TRD capture high FP 
rates. A comprehensive approach to evaluating recognition memory function that 
includes the examination of other indices in addition to (not instead of) standardized TRD 
scores, which are relied upon by default for making clinical judgments about the nature 
of recognition memory abilities and dysfunction, is encouraged. The present findings 
may have important implications when making comparisons between CVLT-I and 
CVLT-II findings regarding TRD in HD and AD and in improving efforts to accurately 
characterize recognition memory function in these populations. 
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Tables 
 
Table 2.1. Gender distribution and mean values (standard deviations) of age and 
education for individuals with Huntington’s disease (HD), healthy middle-aged adults 
(MA), individuals with Alzheimer’s disease (AD), and healthy older adults (OA). 
 
  
Variable HD MA AD OA
n 58 68 33 35
% Female 57% 47% 24% 46%
Age (years) 48.03 (9.58) 43.63 (15.56) 76.55 (8.60) 75.80 (8.82)
Education (years) 14.33 (2.15) 15.15 (2.17) 15.00 (2.69) 16.06 (1.86)
DRS-2 (total score) 123.78 (12.94) N/A 119.55 (7.61) N/A
Note: DRS-2 = measure of global cognitive functioning.
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Table 2.2. Inferential and descriptive statistics for all planned group comparisons on 
TRD indices. 
 
  
Index HD MA Test Statistic p r d
Nonp 76.90 (12.40) 94.67 (7.91) U = 386.50 <.001 .70 1.94
d' 1.71 (0.88) 3.40 (0.73) U = 328.00 <.001 .72 2.08
z d' -1.78 (1.25) 0.44 (0.95) U = 354.50 <.001 .71 2.02
Index AD OA Test Statistic p r d
Nonp 58.96 (12.24) 90.65 (6.50) U = 0.50 <.001 .86 3.37
d' 0.68 (0.61) 2.83 (0.68) U = 7.50 <.001 .85 3.21
z d' -2.14 (0.89) 0.34 (0.79) U = 19.00 <.001 .84 3.04
Index HD AD Test Statistic p r d
Nonp 76.90 (12.40) 58.96 (12.24) F(1,88) = 37.41 <.001 .28 0.16
d' 1.71 (0.88) 0.68 (0.61) F(1,88) = 34.27 <.001 .27 0.15
z d' -1.78 (1.25) -2.14 (0.89) U = 807.50 .21 .13 0.26
HD vs MA
AD vs OA
HD vs AD
Note: Nonp = raw nonparametric TRD score; d' = raw parametric TRD score; z d'  = standardized 
parametric TRD score.
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Table 2.3. Fisher's r to z transformations of group effects on raw nonparametric versus 
parametric TRD scores. 
 
  
Nonp d'
Comparison n r1 r2 z p
HD vs MA 126 .70 .72 0.32 .75
AD vs OA 68 .86 .85 0.21 .83
HD vs AD 91 .28 .27 0.07 .94
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CHAPTER 3: 
Study 2 
The content within this section, titled “Chapter 3: Study 2,” reflects material from 
a paper that has been published in Aging, Neuropsychology, and Cognition.  The proper 
citation is as follows: 
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Abstract 
The present study examined age-related changes in the four false positive (FP) 
error subtypes found on the California Verbal Learning Test—Second Edition (CVLT-II) 
yes/no recognition memory trial and the influence of the different subtypes on 
calculations of d’ scores on indices of source and novel recognition discriminability 
(SoRD and NRD, respectively). Healthy young (n = 57) and older (n = 55) adults 
exhibited different patterns of FP errors; nonetheless, older adults generally made more 
FP errors than young adults. Accordingly, older adults also performed worse than young 
adults on all SoRD and NRD indices. Moreover, the magnitudes of observed differences 
between and within the two age groups on SoRD and NRD indices were shown to vary 
depending on the manner in which FP error subtypes were incorporated into calculations 
of d’ scores. The present findings underline the importance of examining FP errors in the 
assessment of recognition memory abilities, and using refined indices of recognition 
discriminability to further elucidate the nature of age-related recognition memory 
impairment. Furthermore, the present findings highlight the potential for these refined 
indices to demonstrate clinical utility through enhancing characterizations of memory 
loss in more cognitively impaired populations. 
 
Keywords: aging, source memory, item memory, recognition discriminability, California 
Verbal Learning Test 
    
 42 
Refining CVLT-II Recognition Discriminability Indices to Enhance the 
Characterization of Recognition Memory Changes in Healthy Aging 
The human life expectancy in the United States has continuously risen over the 
last several decades. Age is currently the greatest known risk factor for 
neurodegenerative disease. As the human life expectancy continues to rise, the burden of 
cognitive decline in older age and the prevalence of dementia due to neurodegenerative 
disease are expected to increase. The development and use of more refined assessments 
will be important for enhancing characterizations of the cognitive strengths and 
weaknesses associated with healthy aging. 
Memory loss is one of the most common cognitive issues that arise in older age. 
Although memory loss, generally speaking, is associated with aging, evidence suggests 
that not all aspects of memory show an equal rate or magnitude of age-related decline. 
For example, several studies have shown that the effect of aging is greater on source 
memory than on item memory (Bayer et al. 2011; Dennis et al., 2008; Glisky & Kong, 
2008; Hashtroudi, Johnson, & Chrosniak, 1989; McIntyre & Craik, 1987; Naveh-
Benjamin & Craik, 1995; Schacter, Kaszniak, Kihlstrom, & Valdiserri, 1991; Spaniol, 
Madden, & Voss, 2006; Trott, Friedman, Ritter, Fabiani, & Snodgrass, 1999). Source 
memory relates to the context from which information was learned or acquired, whereas 
item memory relates to content of such information regardless of its source. In other 
words, item memory refers to the ability to remember what happened, whereas source 
memory refers to the ability to remember where, when, and how it happened (Dennis et 
al., 2008). It has been suggested that impaired encoding of contextual information 
accounts for poorer performance among older adults on source memory tasks (Johnson, 
 43 
Hashtroudi, & Lindsay, 1993). Specifically, age-related dysfunction may result in the 
inability to engage mnemonic processes for integrating contextual information with item 
memory during encoding. Moreover, older adults may possess only enough cognitive 
resources to encode the stimulus itself, at the expense of also encoding contextual 
information (i.e., are stimulus bound), resulting in poorer recall of such contextual (or 
source) information (Glisky & Kong, 2008; Johnson et al., 1993). 
Memory for the context (i.e., source) and content of an episodic event may rely on 
different brain regions. Neuroimaging studies and studies involving patients with focal 
brain lesions have shown that source memory may rely on the functional integrity of both 
the frontal and temporal lobes (Awipi & Davachi, 2008; Cansino, Maquet, Dolan, & 
Rugg, 2002; Ekstrom & Bookheimer, 2007; Janowsky, Shimamura, & Squire, 1989; 
Kirwan, Wixted, & Squire, 2008; Mitchell, Raye, Johnson, & Greene, 2006; Peters, 
Koch, Schwarz, & Daum, 2007; Peters, Suchan, Koster, & Daum, 2007). Accordingly, 
age-related pathology of the frontal and temporal regions may account for the source 
memory decline that is often observed in normal aging (Dennis et al., 2008; Fan, 
Snodgrass, & Bilder, 2003; Glisky & Kong, 2008; Glisky, Rubin, & Davidson, 2001; 
Henkel, Johnson, & De Leonardis, 1998; Mitchell et al., 2006). Other studies have 
indicated that the frontal lobes, in particular, are strongly implicated in source memory 
(Craik, Morris, Morris, & Loewen, 1990; Fan et al., 2003; Glisky, Polster, & Routhieaux, 
1995; Glisky et al., 2001; Janowsky et al., 1989; Schacter, Harbluk, & McLachlan, 1984), 
whereas the medial temporal lobes may be more involved in item memory (Shimamura & 
Squire, 1987; Stark & Squire, 2000, 2003). 
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Recognition memory is a component of declarative memory that involves the 
ability to recognize previously encountered stimuli. Although not affected to the same 
degree as recall, recognition memory has been shown to decline with age (Craik & 
McDowd, 1987; Danckert & Craik, 2013). The original and second editions of the 
California Verbal Learning Test (CVLT-I and CVLT-II, respectively; Delis, Kramer, 
Kaplan, & Ober, 1987, 2000) are widely used in research and clinical settings and have 
been utilized in efforts to characterize memory function and decline in healthy aging. In 
general, older adults have been shown to exhibit worse performances relative to young 
adults on indices of recall, and, to a lesser extent, recognition (Delis et al., 1987; Ebert & 
Anderson, 2009; Kausler, 1994; Turner & Pinkston, 1993; Van der Linden, Philippot, & 
Heinen, 1997; Woodruff-Pak & Finkbiner, 1995). 
Further exploration of more nuanced aspects of recognition memory function may 
provide additional valuable insight into the cognitive changes that accompany healthy 
aging. Since the mid to late twentieth century, signal detection theory (SDT) has been 
applied in studies of recognition memory as a gold standard for assessing recognition 
memory function that takes sensitivity and response bias into account. Delis and 
colleagues included a recognition discriminability index on the CVLT-I (Delis et al., 
1987), and introduced additional subtypes of recognition discriminability on the CVLT-II 
(Delis et al., 2000). These CVLT-II indices are calculated using d’ (Macmillan & 
Creelman, 1991). In addition to total recognition discriminability, the CVLT-II provides 
an index of source recognition discriminability (SoRD), which captures the ability to 
distinguish List A target items from List B distractor items on the CVLT-II yes/no 
recognition memory trial. Thus, the SoRD index, although not a direct measure of source 
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memory per se, taps into aspects of source memory by measuring one’s ability to 
distinguish whether a word was included on List A or List B. Half of the List B distractor 
items are prototypical, or semantically related to target items, rendering them perhaps 
more challenging to identify as distractors than the other half of the List B distractor 
items, which are semantically unrelated (e.g., Baddeley, 1966). Thus, a SoRD index that 
excludes contributions from FP errors related to prototypical distractors and therefore 
more specifically captures the ability to distinguish List A target items from List B 
distractor items that are not semantically related to target items may yield a more refined 
assessment of SoRD. 
The CVLT-II also includes an index of novel recognition discriminability (NRD), 
which captures the ability to distinguish List A target items from novel (i.e., non-List B) 
distractor items. Thus, the NRD index represents recognition memory in a more 
traditional sense, providing a measure of one’s ability to distinguish “old” stimuli (i.e., 
target items) from “new” stimuli (i.e., novel distractor items). Half of the novel distractor 
items are prototypical, or semantically related to target items, rendering them more 
challenging to identify as distractors than the other half of the novel distractor items, 
which are semantically unrelated. Thus, a NRD index that excludes contributions from 
FP errors related to prototypical distractors and therefore more specifically captures the 
ability to distinguish List A target words from novel distractor items that are semantically 
unrelated to target items may provide a more refined assessment of NRD. 
In addition to SoRD and NRD, the CVLT-II provides a third subtype of 
recognition discriminability called semantic recognition discriminability (SeRD) that 
captures the ability to distinguish List A target items from distractor items that are 
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semantically related to target items, including those that are from List B as well as those 
that are novel (Delis et al., 2000). In contrast, the SoRD and NRD indices reflect the 
ability to distinguish targets from List B and novel distractors, respectively, without 
parsing the contributions of prototypical, or semantically related distractors from those of 
semantically unrelated distractors. 
On that premise, the extent to which between- and within-group differences in 
SoRD and NRD performances may be influenced by the degree of semantic association 
between targets and distractors found on the CVLT-II yes/no recognition memory trial 
has not been explored. Thus, the present study has two main objectives. First, between- 
and within-group differences in FP errors in each of the four subtypes that are found on 
the CVLT-II yes/no recognition memory trial (prototypical List B, unrelated List B, 
prototypical novel, and unrelated novel) will be examined in healthy older (n = 55) and 
young (n = 57) adults. Second, between- and within-group differences in d’ scores were 
examined on three variations of the SoRD and NRD indices: 1) original SoRD and NRD 
(which include both prototypical and semantically unrelated List B and novel distractors 
in d’ calculations), 2) SoRD-prototypical and NRD-prototypical (which include 
prototypical List B and novel distractors only in d’ calculations), and 3) SoRD-unrelated 
and NRD-unrelated (which include semantically unrelated List B and novel distractors 
only in d’ calculations). Older adults are expected to make more FP errors than young 
adults, although it is hypothesized that the two age groups may exhibit different patterns 
of FP errors across the four subtypes. Additionally, older adults are expected to perform 
worse than young adults on all SoRD and NRD indices, albeit to a lesser extent on 
indices that exclude prototypical distractors. In particular, the SoRD-unrelated and NRD-
 47 
unrelated indices are expected to be associated with smaller group differences than the 
SoRD and NRD indices. Furthermore, both age groups are expected to demonstrate better 
performances on SoRD-unrelated and NRD-unrelated indices than on SoRD and NRD 
indices, and older adults are generally expected to exhibit worse performances on SoRD 
than on NRD. Findings from the present study may help to elucidate the nature of 
recognition memory function and changes in healthy aging with the use of more refined 
measures of recognition discriminability. 
Method 
Participants 
Study participants included 57 healthy young adults (18-25 years of age) and 55 
healthy older adults (65 years of age or older). Older adults were characterized as 
cognitively healthy based on Dementia Rating Scale-2 (DRS-2; Jurica, Leitten, & Mattis, 
2001) scores (130 or above). Exclusionary criteria for all healthy adult participants 
included the following: a diagnosis of any neurological disorder, a diagnosis of any major 
medical condition (e.g., cancer), a diagnosis of any psychiatric disorder (with the 
exception of a mood disorder, for which any current symptoms must be well managed), a 
history of traumatic brain injury, and a history of substance abuse. All participants 
provided informed written consent and the study was approved by the Institutional 
Review Boards of San Diego State University (SDSU) and/or the University of 
California, San Diego (UCSD). 
Healthy young adults were recruited from the San Diego community by the 
Center for Healthy Aging and Neurodegenerative Disease Research (CHANDR) at SDSU 
and the Huntington’s Disease Clinical Research Program (HDCRP) at UCSD. Healthy 
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older adults were recruited from the San Diego community by CHANDR at SDSU, the 
Normal Aging Laboratory at UCSD, and the HDCRP at UCSD. Participants were 
administered a standardized battery of neuropsychological tests by trained research 
assistants or psychometrists. CVLT-II data from the subset of healthy older adults 
recruited by the Normal Aging Laboratory were extracted from an archival database that 
included data from a larger battery of neuropsychological tests administered at the 
Shiley-Marcos Alzheimer’s Disease Research Center (ADRC) in La Jolla and the 
Veterans Affairs San Diego Healthcare System (VASDHS). 
CVLT-II and Recognition Discriminability (RD) Indices 
The CVLT-II was administered using standard procedures outlined by Delis and 
colleagues (2000). The CVLT-II is a list-learning test that provides a multitude of verbal 
learning and memory indices, including immediate recall, free and cued recall over short 
and long delays, and recognition memory. The RD indices that were of primary interest 
in the present study were generated using variables derived from the yes/no recognition 
memory trial on the CVLT-II. Short- and long-delay tests of recall were separated by an 
interval of approximately 20 minutes, during which other nonverbal neuropsychological 
measures were administered. CVLT-II data were scored using CVLT-II scoring software 
(Delis & Fridlund, 2000). Raw scores on hits, the four FP error subtypes [prototypical 
List B (used in calculating the SoRD-prototypical index), unrelated List B (used in 
calculating the SoRD-unrelated index), prototypical novel (used in calculating the NRD-
prototypical index), and unrelated novel (used in calculating the NRD-unrelated index)], 
and the six RD indices (SoRD, SoRD-prototypical, SoRD-unrelated, NRD, NRD-
prototypical, and NRD-unrelated) were examined. 
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SoRD and NRD indices are calculated using the following formulas (Delis et al., 
2000): 
1. SoRD (d’) = z(hits) – z(FP errors associated with prototypical List B 
distractors + FP errors associated with semantically unrelated List B 
distractors) 
2. NRD (d’) = z(hits) – z(FP errors associated with prototypical novel distractors 
+ FP errors associated with semantically unrelated novel distractors) 
SoRD-prototypical, SoRD-unrelated, NRD-prototypical, and NRD-unrelated indices 
were generated using the following formulas: 
3. SoRD-prototypical (d’) = z(hits) – z(FP errors associated with prototypical 
List B distractor items only) 
4. SoRD-unrelated (d’) = z(hits) – z(FP errors associated with unrelated List B 
distractor items only) 
5. NRD-prototypical (d’) = z(hits) – z(FP errors associated with prototypical 
novel distractor items only) 
6. NRD-unrelated (d’) = z(hits) – z(FP errors associated with unrelated novel 
distractor items only) 
Raw d’ scores are computed by calculating inverse proportions of hits and respective FP 
errors and subtracting respective FP error rates from hit rates (see Macmillan & 
Creelman, 1991). 
Statistical Analyses 
Analyses were conducted in the Statistical Package for the Social Sciences 
(SPSS) Version 24. Prior to examining age group differences in hits, the four FP error 
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subtypes, and the six RD indices of interest, chi-square analyses and one-way analysis of 
variance (ANOVA) tests were conducted to determine whether gender and education, 
respectively, were significant predictors of the outcome variables (hits, FP errors, RD 
indices). Gender and education were not significant predictors of the particular outcome 
variables of interest in the present study and therefore were not controlled for in the 
primary analyses. 
Shapiro-Wilk tests of normality revealed that all outcome variables were non-
normally distributed (ps < .05). Thus, nonparametric analyses were conducted to address 
the aims of the present study. 
Analysis of hits. A Mann-Whitney U test was conducted to examine the age 
group difference in the number of hits on the CVLT-II yes/no recognition memory trial. 
Analyses of FP error subtypes. Due to the substantial number of zero FP errors 
across subtypes and individuals, separate chi-square analyses were conducted to examine 
differences between the two age groups in the number of individuals who made zero FP 
errors versus one or more FP errors in each of the four subtypes. Additionally, separate 
chi-square tests of independence were conducted to make pairwise comparisons of the 
four FP error subtypes within each age group. Effect size values (r) were calculated to 
quantify and compare the magnitudes of significant between- and within-group 
differences in FP error subtypes [r = √(2/N)]. 
Analyses of RD indices. Six separate Mann-Whitney U tests were conducted to 
examine age group differences in d’ scores on the six RD indices of interest (SoRD, 
SoRD-prototypical, SoRD-unrelated, NRD, NRD-prototypical, and NRD-unrelated). 
Additionally, two separate Friedman tests were conducted to examine the effect of RD 
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index type on d’ scores within each group. If a significant omnibus effect of RD index 
type was observed, nine follow-up Wilcoxon signed-rank tests were conducted to make 
the following pairwise comparisons within a particular age group: 1) SoRD vs. NRD, 2) 
SoRD-prototypical vs. NRD-prototypical, 3) SoRD-unrelated vs. NRD-unrelated, 4) 
SoRD vs. SoRD-prototypical, 5) SoRD vs. SoRD-unrelated, 6) SoRD-prototypical vs. 
SoRD-unrelated, 7) NRD vs. NRD-prototypical, 8) NRD vs. NRD-unrelated, and 9) 
NRD-prototypical vs. NRD-unrelated. Effect size values (r) were calculated to quantify 
and compare the magnitudes of significant between- and within-group differences in d’ 
scores on RD indices (r = Z/√N). 
False discovery rate adjustment. Adjustments for a false discovery rate (FDR) 
of .05 (see Benjamini & Hochberg, 1995) were applied in the analyses of between- and 
within-group differences on FP error subtypes and RD indices. Original p values are 
presented in the study tables, and asterisks indicate which p values retained significance 
following FDR adjustments. 
Results 
Demographic Information 
A chi-square analysis revealed no difference between the older (49.09% women) 
and young (57.89% women) adult groups in their proportions of men and women, 2 (2, 
N = 112) = 0.87, p = .45. A one-way ANOVA revealed that older adults (M = 16.36, SD 
= 2.08) completed more years of education than young adults (M = 14.28, SD = 2.21), 
F(1, 110) = 31.64, p < .001. All older adults had DRS-2 scores of 130 or higher (M = 
140.62, SD = 2.96). 
Analysis of Hits 
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A Mann-Whitney U test revealed that older adults (mean rank = 50.15, sum of 
ranks = 2758.50) had significantly fewer hits on the CVLT-II yes/no recognition memory 
trial than young adults (mean rank = 62.62, sum of ranks = 3569.50), U = 1218.50, p < 
.05. 
Analyses of FP Error Subtypes 
Age group differences in FP error subtypes. Descriptive and inferential 
statistics for age group differences in the number of individuals who made zero versus 
one or more FP errors in each of the four subtypes are provided in Table 3.1. Proportions 
of older and young adults who made one or more FP errors in each of the four subtypes 
are illustrated in Figure 3.1. Chi-square analyses revealed that the extent to which the 
number of individuals who made zero FP errors was higher than the number of 
individuals who made one or more FP errors was smaller in the older adult group than in 
the young adult group in three of the four FP error subtypes: prototypical List B, 
unrelated List B, and prototypical novel (i.e., the proportion of individuals who made one 
or more FP errors was larger in the older adult group than in the young adult group in the 
three aforementioned subtypes). No age group difference in the extent to which the 
number of individuals who made zero FP errors was higher than the number of 
individuals who made one or more FP errors was observed in the unrelated novel 
subtype. 
Within-group differences in FP error subtypes. Inferential statistics for 
comparisons within each age group in the number of individuals who made zero versus 
one or more FP errors across subtypes are provided in Table 3.2. Proportions of 
individuals who made one or more FP errors across subtypes within each age group are 
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illustrated in Figure 3.2. Chi-square analyses revealed different patterns of FP errors 
within the older adult, 2 (3, N = 55) = 30.48, p <.001, and young adult, 2 (3, N = 57) = 
14.15, p <.01, groups. In the older adult group, the proportion of individuals who made 
one or more FP errors was 1) greater for the prototypical List B and prototypical novel 
subtypes than the unrelated List B and unrelated novel subtypes, respectively, 2) greater 
for the unrelated List B subtype than the unrelated novel subtype, 3) greater for the 
prototypical novel subtype than the unrelated List B subtype, and 4) greater for the 
prototypical List B subtype than the unrelated novel subtype. In the young adult group, 
the proportion of individuals who made one or more FP errors was greater for the 
prototypical novel subtype than the unrelated novel subtype; however, no other 
comparisons within the young adult group were significant. 
Analyses of RD Indices 
Age group differences on RD indices. Mean and standard deviation values as 
well as 25th, 50th (median), and 75th percentile values of the older and young adult groups 
on all six RD indices are provided in Table 3.3. Descriptive and inferential statistics for 
age group differences on RD indices are provided in Table 3.4. Mann-Whitney U tests 
revealed that older adults performed significantly worse than young adults on all six RD 
indices. 
Comparisons of effect sizes for age group differences on RD indices. Although 
analyses revealed that older adults performed significantly worse than young adults on all 
RD indices, effect sizes associated with the observed age group differences on RD 
indices were compared to elucidate the extent to which incorporating FP errors associated 
with prototypical distractors only, unrelated distractors only, or both prototypical and 
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unrelated distractors in calculating SoRD and NRD scores impacted observed age group 
differences. The effect size associated with the age group difference on the SoRD-
unrelated index (List A targets vs. unrelated List B distractors only) was 24.24% smaller 
than the effect size associated with the age group differences on the SoRD (List A targets 
vs. all List B distractors) and SoRD-prototypical (List A targets vs. prototypical List B 
distractors only) indices, which were comparable. Additionally, the effect size associated 
with the age group difference on the NRD-unrelated index (List A targets vs. unrelated 
novel distractors only) was 38.89% smaller than the effect size associated with the age 
group difference on the NRD index (List A targets vs. all novel distractors), but was 
comparable to the effect size associated with the age group difference on the NRD-
prototypical index (List A targets vs. prototypical novel distractors only). In sum, the 
extent to which older adults performed worse than young adults was smaller on the 
SoRD-unrelated and NRD-unrelated indices than on the SoRD and NRD indices. 
The effect size associated with the age group difference on the SoRD index was 
8.33% smaller than the effect size associated with the age group difference on the NRD 
index. In contrast, the effect size associated with the age group difference on the SoRD-
prototypical index was 50.00% larger than the effect size associated with the age group 
difference on the NRD-prototypical index. Finally, the effect size associated with the age 
group difference on the SoRD-unrelated index was 13.64% larger than the effect size 
associated with the age group difference on the NRD-unrelated index. Thus, a larger age 
group difference on SoRD relative to NRD was observed on SoRD and NRD indices that 
included either FP errors associated with prototypical distractors only (i.e., SoRD-
prototypical and NRD-prototypical) or semantically unrelated distractors only (i.e., 
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SoRD-unrelated and NRD-unrelated), although the difference was substantially smaller 
in the context of the latter indices. 
Within-group differences on RD indices. Descriptive and inferential statistics 
for within-group differences on RD indices are provided in Table 3.5. Friedman tests 
revealed a significant effect of RD index type within both the older adult, 2 (5, N = 55) = 
104.77, p <.001, and young adult, 2 (5, N = 57) = 161.39, p <.001, groups. Wilcoxon 
signed-rank tests revealed different patterns of performances on RD indices within the 
older and young adult groups. 
In the older adult group, scores were higher on the SoRD-unrelated index than on 
the SoRD and SoRD-prototypical indices; however, scores were comparable on the latter 
two indices. Additionally, scores were higher on the NRD-unrelated index than on the 
NRD and NRD-prototypical indices, although scores were comparable on the latter two 
indices (after an FDR adjustment). Furthermore, in the older adult group, scores were 
comparable on the SoRD and NRD indices, on the SoRD-prototypical and NRD-
prototypical indices, and on the SoRD-unrelated and NRD-unrelated indices (after an 
FDR adjustment). 
Performances on RD indices in the young adult group largely mirrored the pattern 
of performances that was observed in the older adult group. For example, scores were 
higher on the SoRD-unrelated index than on the SoRD index; however, in contrast to the 
older adult group, scores also were higher on the SoRD-prototypical index than on the 
SoRD index, and scores on the SoRD-prototypical and SoRD-unrelated indices were 
comparable. Additionally, scores were higher on the NRD-unrelated index than on the 
NRD and NRD-prototypical indices, although scores were comparable on the latter two 
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indices. Furthermore, in the young adult group, scores were comparable on the SoRD and 
NRD indices, on the SoRD-prototypical and NRD-prototypical indices, and on the 
SoRD-unrelated and NRD-unrelated indices. 
Discussion 
The present study demonstrated that FP errors associated with prototypical 
distractors substantially influence calculations of SoRD and NRD scores on the CVLT-II 
yes/no recognition memory trial. The examination of age group differences in FP errors 
revealed that, compared to young adults, a greater proportion of older adults made FP 
errors associated with prototypical List B, prototypical novel, and unrelated List B 
distractors. However, the two age groups did not differ in proportions of individuals who 
made FP errors associated with unrelated novel distractors. This finding is expected given 
that these items are generally conceptualized as the least challenging to identify as 
distractors or “non-targets” due to being both novel (i.e., were not presented at any point 
during task administration) and semantically unrelated – and therefore less similar – to 
target items. 
Analyses also demonstrated that the two age groups yielded different patterns in 
proportions of individuals who made FP errors across the four subtypes. In particular, the 
pattern of FP errors within the older adult group suggests an age-related vulnerability to 
the effect of semantic interference from prototypical items on yes/no recognition testing, 
over and above an effect of source interference from List B items. In the older adult 
group, there was a greater proportion of individuals who made FP errors associated with 
distractors that are prototypical, or semantically related to targets (regardless of whether 
the items were from List B or novel) than there was of those who made FP errors 
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associated with non-prototypical, or semantically unrelated distractors. Moreover, there 
was a greater proportion of individuals who made FP errors associated with prototypical 
novel distractors (which present only semantic interference) than there was of those who 
made FP errors associated with unrelated List B distractors (which present only source 
interference). Furthermore, the proportions of individuals who made FP errors associated 
with prototypical List B distractors (which present both semantic and source interference) 
and prototypical novel distractors (which present only semantic interference) were 
comparable. These findings may imply that healthy older adults are even more vulnerable 
to semantic interference than source interference (i.e., experience even greater difficulty 
in identifying prototypical items as distractors, than in identifying List B items as 
distractors as a result of age-related source memory impairment) on the CVLT-II yes/no 
recognition memory trial. However, in the analysis of semantically unrelated distractors, 
there was a greater proportion of individuals who made FP errors associated with items 
that were from List B than those that were novel, which is not surprising given the 
research literature on age-related source memory impairment. Taken together, this set of 
findings regarding FP errors in the older adult group suggests that 1) older adults are 
particularly susceptible to inaccurately endorsing prototypical distractors over and above 
experiencing difficulty in identifying List B items as distractors, and 2) in the context of 
semantically unrelated distractors only, continue to exhibit difficulty in identifying List B 
items as distractors. These findings provide more evidence of age-related source memory 
impairment as well as highlight that prototypical items, by introducing semantic 
interference, are an additional source of confusion or difficulty for healthy older adults on 
yes/no recognition memory testing. 
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In the young adult group, there was a greater proportion of individuals who made 
FP errors associated with prototypical distractors than there was of those who made FP 
errors associated with semantically unrelated distractors, only with regard to novel 
distractor items. Thus, young adults also may be prone to inaccurately endorsing 
prototypical distractors, albeit to a lesser extent than older adults based on an examination 
of effect sizes (see Table 3.2), although, in contrast to older adults, they are less likely to 
experience difficulty in aspects of yes/no recognition memory testing that rely on source 
memory (i.e., identifying List B items as distractors). 
The examination of age group differences on SoRD, SoRD-prototypical, SoRD-
unrelated, NRD, NRD-prototypical, and NRD-unrelated indices revealed that older adults 
performed significantly worse than young adults on all indices. Moreover, effect sizes 
associated with the observed age group differences on RD indices were compared to 
elucidate the extent to which incorporating FP errors associated with prototypical 
distractors only, unrelated distractors only, or both prototypical and unrelated distractors 
in calculating SoRD and NRD scores impacted observed age group differences. A 
particular emphasis was made on comparing the degree to which older and young adults 
differed on new, more refined SoRD and NRD indices that exclude FP errors associated 
with prototypical distractors (i.e., SoRD-unrelated and NRD-unrelated) relative to 
existing CVLT-II SoRD and NRD indices that include FP errors associated with both 
prototypical and semantically unrelated distractors. As expected, the effect sizes 
associated with age group differences on SoRD-unrelated and NRD-unrelated indices 
were smaller than the effect sizes associated with age group differences on SoRD and 
NRD indices, respectively. The reduction in age group differences is likely driven by the 
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notion that older adults showed greater improvements relative to young adults on indices 
that exclude FP errors associated with prototypical distractors, based on an examination 
of effect sizes. Analyses also revealed that the effect size associated with the age group 
difference on the SoRD index was smaller than the effect size associated with the age 
group difference on the NRD index. In contrast, the effect size associated with the age 
group difference on the SoRD-unrelated index was larger than the effect size associated 
with the age group difference on the NRD-unrelated index (this pattern was even more 
evident in the context of SoRD-prototypical and NRD-prototypical indices). In sum, this 
set of findings indicates that, by excluding contributions from FP errors associated with 
prototypical distractor items that are semantically related to target items in the calculation 
of SoRD and NRD scores, 1) age group differences on SoRD and NRD are smaller in 
magnitude, and 2) the extent to which older adults perform worse than young adults is 
greater on SoRD than on NRD, which further supports the notion that, relative to item 
memory, source memory is particularly vulnerable to age-related decline (Bayer et al., 
2011; Dennis et al., 2008; Glisky & Kong, 2008; Hashtroudi, Johnson, & Chrosniak, 
1989; McIntyre & Craik, 1987; Naveh-Benjamin & Craik, 1995; Schacter, Kaszniak, 
Kihlstrom, & Valdiserri, 1991; Spaniol, Madden, & Voss, 2006; Trott, Friedman, Ritter, 
Fabiani, & Snodgrass, 1999). A possible limitation of these findings is that the older adult 
group in the study sample was relatively well educated and may not fully represent the 
general population of cognitively healthy older adults. However, it is reasonable to 
suspect that observed age group differences on RD indices would be larger in a sample of 
individuals with less cognitive reserve. Moreover, the present findings highlight the 
potential for these refined RD indices to demonstrate clinical utility in the assessment and 
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characterization of recognition memory deficits in more cognitively impaired 
populations, such as individuals with neurodegenerative disease. 
Analyses revealed different patterns of within-group differences on RD indices 
across the two age groups. In the older adult group, performances were higher on the 
SoRD-unrelated index than on the SoRD and SoRD-prototypical indices, whereas 
performances were comparable on the latter two indices. These findings suggest a 
significant influence of FP errors related to prototypical List B distractors on SoRD 
performances in older adults, and further highlight the cumulative effects of source and 
semantic interference on increasing the difficulty of identifying distractor items for older 
adults. Similarly, performances were higher on the NRD-unrelated index than on the 
NRD and NRD-prototypical indices, whereas performances were comparable on the 
latter two indices, suggesting a significant influence of FP errors related to prototypical 
novel distractors on NRD performances in older adults, and further highlighting the 
impact of semantic interference on yes/no recognition testing in older adults. 
Performances on the SoRD-prototypical and NRD-prototypical indices (and on the SoRD 
and NRD indices) were comparable, which is not surprising given that the proportions of 
older adults who made FP errors associated with prototypical List B and prototypical 
novel distractors were comparable. However, performances on the SoRD-unrelated and 
NRD-unrelated indices also were comparable despite the observation that the proportion 
of older adults who made FP errors associated with unrelated List B distractors was 
greater than the proportion of older adults who made FP errors associated with unrelated 
novel distractors. Nonetheless, this set of findings collectively suggests that older adults 
do benefit from the exclusion of FP errors associated with prototypical distractor items in 
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the calculation of d’ scores for SoRD and NRD. Moreover, the findings suggest that 
disproportionate source memory impairments in older adults may be more evident in the 
close examination of FP errors, rather than through comparisons of scores on SoRD 
indices relative to NRD indices. 
In the young adult group, performances were higher on the SoRD-unrelated and 
NRD-unrelated indices than on the SoRD and NRD indices, respectively. Moreover, 
performances were comparable on the SoRD and NRD indices, on the SoRD-prototypical 
and NRD-prototypical indices, and on the SoRD-unrelated and NRD-unrelated indices. 
Taken together, these results suggest that young adults also do benefit from the exclusion 
of FP errors associated with prototypical distractor items in the calculation of d’ scores 
for SoRD and NRD. Nonetheless, disproportionate source or novel recognition memory 
impairments among young adults were not observed in analyses of FP errors or RD 
indices, which is not surprising given that relative weaknesses in source or item memory 
are not typically observed in young adulthood. 
Overall, the present findings yield evidence for improved performances among 
both older and young adults on SoRD and NRD indices that exclude FP errors associated 
with prototypical distractor items in the calculation of d’ scores. Moreover, the present 
findings highlight the important role of FP errors in the assessment of recognition 
discriminability and efforts to characterize recognition memory function and changes in 
healthy aging. 
Conclusion 
The present study examined the impact of different FP error subtypes on 
assessments of SoRD and NRD using the CVLT-II in a cognitively healthy sample, and 
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the degree of age-related differences on SoRD and NRD indices that exclude 
contributions from FP errors associated with prototypical distractors (i.e., SoRD-
unrelated and NRD-unrelated) relative to age-related differences on original SoRD and 
NRD indices that include FP errors associated with both prototypical and semantically 
unrelated distractors. Both age groups demonstrated better performances on SoRD-
unrelated and NRD-unrelated indices than on SoRD and NRD indices, respectively. 
Although older adults performed worse than young adults on all RD indices, age group 
differences were smaller in magnitude on the more refined SoRD-unrelated and NRD-
unrelated indices relative to original SoRD and NRD indices, although older adults were 
shown to perform disproportionately worse than young adults on SoRD in the context of 
refined indices. Although CVLT-II indices of SoRD and NRD in their current form can 
reliably demonstrate age-related differences on these aspects of recognition memory 
function (i.e., those pertaining to source and item memory), the refined indices utilized in 
the present study may be used to further elucidate the extent to which healthy older and 
young adults differ on these particular constructs. Furthermore, the present findings 
highlight the potential for these refined RD indices to exhibit clinical utility in improving 
assessments and characterizations of recognition memory deficits in more cognitively 
impaired populations. 
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Figures 
 
 
Figure 3.1. Proportions of older and young adults who made one or more (1+) FP errors 
in each of the four subtypes: prototypical List B, prototypical novel, unrelated List B, and 
unrelated novel. Asterisks (*) indicate significant group differences. 
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Figure 3.2. Proportions of individuals who made one or more (1+) FP errors across 
subtype (prototypical List B, prototypical novel, unrelated List B, and unrelated novel) 
within each age group. Asterisks (*) indicate significant pairwise comparisons within 
groups. 
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Tables 
 
Table 3.1. Age group differences in the number of individuals who made zero (0 FP) 
versus one or more (1+ FP) FP errors in each of the four subtypes, based on chi-square 
analyses. 
 
  
0 FP 1+ FP
Proportion 
of 1+ FP
0 FP 1+ FP
Proportion 
of 1+ FP
Prototypical List B 30 25 .455 50 7 .123 15.09 <.001* .37
Prototypical Novel 28 27 .491 44 13 .228 8.42 <.01* .27
Unrelated List B 43 12 .218 53 4 .070 5.01 <.05* .21
Unrelated Novel 51 4 .073 56 1 .018 2.00 .202 .13
*p value retains significance following FDR adjustment
FP Error Subtype rχ2 p
Older Young
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Table 3.2. Comparisons within each age group in the number of individuals who made 
zero versus one or more FP errors across subtypes, based on chi-square tests of 
independence. 
 
  
χ2 p r χ2 p r
Prototypical List B vs. Unrelated List B 6.88 <.01* .25 0.91 .341 .09
Prototypical List B vs. Prototypical Novel 0.15 .702 .04 2.18 .140 .14
Prototypical List B vs. Unrelated Novel 20.65 <.001* .43 4.84 <.05 .21
Unrelated List B vs. Prototypical Novel 8.94 <.01* .28 5.60 <.05 .22
Unrelated List B vs. Unrelated Novel 4.68 <.05* .20 1.88 .170 .13
Prototypical Novel vs. Unrelated Novel 23.76 <.001* .46 11.73 <.001* .32
*p value retains significance following FDR adjustment
Older Young
Comparison
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Table 3.3. Descriptive information for older and young adults on all six recognition 
discriminability (RD) indices. 
 
  
Mean (SD) 25th %ile
50th %ile 
(median)
75th %ile Mean (SD) 25th %ile
50th %ile 
(median)
75th %ile
SoRD 2.96 (0.71) 2.40 3.10 3.70 3.40 (0.45) 3.40 3.70 3.70
SoRD-prototypical 3.00 (0.94) 2.04 3.05 4.00 3.61 (0.55) 3.25 4.00 4.00
SoRD-unrelated 3.34 (0.73) 2.99 3.63 4.00 3.67 (0.53) 3.63 4.00 4.00
NRD 2.94 (0.67) 2.40 3.10 3.70 3.40 (0.40) 3.25 3.40 3.70
NRD-prototypical 2.85 (0.98) 2.21 2.77 4.00 3.50 (0.65) 3.05 3.63 4.00
NRD-unrelated 3.52 (0.56) 2.99 3.63 4.00 3.76 (0.34) 3.63 4.00 4.00
Older Young
RD Index
Note: RD = recognition discriminability; SoRD (source recognition discriminability) = List A targets vs. all List B distractors; SoRD-
prototypical = List A targets vs. prototypical List B distractors only; SoRD-unrelated = List A targets vs. unrelated List B distractors only; 
NRD (novel recognition discriminability) = List A targets vs. all novel distractors; NRD-prototypical = List A targets vs. prototypical novel 
distractors only; NRD-unrelated = List A targets vs. unrelated novel distractors only
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Table 3.4. Age group differences on SoRD, NRD, SoRD-unrelated, and NRD-unrelated 
indices, with associated statistics based on Mann-Whitney U tests. 
 
  
Older Young
Mean rank (sum of 
ranks)
Mean rank (sum 
of ranks)
SoRD 45.90 (2524.50) 66.73 (3803.50) 984.50 <.001* .33
SoRD-prototypical 46.12 (2536.50) 66.52 (3791.50) 996.50 <.01* .33
SoRD-unrelated 48.81 (2684.50) 63.92 (3643.50) 1144.50 <.01* .25
NRD 45.06 (2478.50) 67.54 (3849.50) 938.50 <.001* .36
NRD-prototypical 45.35 (2494.50) 67.25 (3833.50) 954.50 <.001* .22
NRD-unrelated 49.70 (2733.50) 63.06 (3594.50) 1193.50 <.05* .22
*p value retains significance following FDR adjustment
RD Index U p r
Note: RD = recognition discriminability; SoRD (source recognition discriminability) = List A targets 
vs. all List B distractors; SoRD-prototypical = List A targets vs. prototypical List B distractors only; 
SoRD-unrelated = List A targets vs. unrelated List B distractors only; NRD (novel recognition 
discriminability) = List A targets vs. all novel distractors; NRD-prototypical = List A targets vs. 
prototypical novel distractors only; NRD-unrelated = List A targets vs. unrelated novel distractors 
only
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Table 3.5. Within-group differences on SoRD, NRD, SoRD-unrelated, and NRD-
unrelated indices, with associated statistics based on Wilcoxon signed-rank tests. 
 
  
Z p r Z p r
SoRD vs. NRD 0.33 .744 .04 0.43 .670 .06
SoRD-prototypical vs. NRD-prototypical 1.36 .173 .18 1.24 .214 .16
SoRD-unrelated vs. NRD-unrelated 2.16 <.05 .29 1.63 .102 .22
SoRD vs. SoRD-prototypical 0.18 .860 .02 4.16 <.001* .55
SoRD vs. SoRD-unrelated 5.83 <.001* .79 5.03 <.001* .67
SoRD-prototypical vs. SoRD-unrelated 3.65 <.001* .49 1.19 .234 .16
NRD vs. NRD-prototypical 2.05 <.05 .28 1.06 .291 .14
NRD vs. NRD-unrelated 6.21 <.001* .84 5.88 <.001* .78
NRD-prototypical vs. NRD-unrelated 4.40 <.001* .59 2.89 <.01* .38
Young
Comparison
Note: RD = recognition discriminability; SoRD (source recognition discriminability) = List A targets vs. 
all List B distractors; SoRD-prototypical = List A targets vs. prototypical List B distractors only; SoRD-
unrelated = List A targets vs. unrelated List B distractors only; NRD (novel recognition discriminability) = 
List A targets vs. all novel distractors; NRD-prototypical = List A targets vs. prototypical novel distractors 
only; NRD-unrelated = List A targets vs. unrelated novel distractors only
Older
*p value retains significance following FDR adjustment
 71 
References 
Awipi, T., & Davachi, L. (2008). Content-specific source encoding in the human medial 
temporal lobe. Journal of Experimental Psychology: Learning Memory and 
Cognition, 34, 769–779. 
Baddeley, A. D. (1966). The influence of acoustic and semantic similarity on long-term 
memory for word sequences. Quarterly Journal of Experimental Psychology, 
18(4), 302–309. 
Bayer, Z. C., Hernandez, R. J., Morris, A. M., Salomonczyk, D., Pirogovsky, E., & 
Gilbert, P. E. (2011). Age-related source memory deficits persist despite superior 
item memory. Experimental Aging Research, 37, 473–480. 
Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical 
and powerful approach to multiple testing. Journal of the Royal Statistical 
Society: Series B (Methodological), 57(1), 289–300. 
Cansino, S., Maquet, P., Dolan, R. J., & Rugg, M. D. (2002). Brain activity underlying 
encoding and retrieval of source memory. Cerebral Cortex, 12, 1048–1056. 
Craik, F. I., & McDowd, J. M. (1987). Age differences in recall and recognition. Journal 
of Experimental Psychology: Learning, Memory, and Cognition, 13(3), 474-479. 
Craik, F. I., Morris, L. W., Morris, R. G., & Loewen, E. R. (1990). Relations between 
source amnesia and frontal lobe functioning in older adults. Psychology and 
Aging, 5, 148–151. 
Danckert, S. L., & Craik, F. I. (2013). Does aging affect recall more than recognition 
memory? Psychology and Aging, 28(4), 902–909. 
Delis, D. C. & Fridlund, A. J. (2000). CVLT-II Comprehensive Scoring System and 
Computerized Report. San Antonio, TX: The Psychological Corporation. 
Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (1987). California Verbal 
Learning Test. San Antonio, TX: The Psychological Corporation. 
Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). California Verbal 
Learning Test–II, Second Edition. San Antonio, TX: The Psychological 
Corporation. 
Dennis, N. A., Hayes, S. M., Prince, S. E., Madden, D. J., Huettel, S. A., & Cabeza, R. 
(2008). Effects of aging on the neural correlates of successful item and source 
memory encoding. Journal of Experimental Psychology: Learning, Memory, and 
Cognition, 34, 791–808.  
 72 
Ebert, P. L., & Anderson, N. D. (2009). Proactive and retroactive interference in young 
adults, healthy older adults, and older adults with amnestic mild cognitive 
impairment. Journal of the International Neuropsychological Society, 15, 83-93. 
Ekstrom, A. D., & Bookheimer, S. Y. (2007). Spatial and temporal episodic memory 
retrieval recruit dissociable functional networks in the human brain. Learning and 
Memory, 14, 645–654. 
Fan, J., Snodgrass, J., & Bilder, R. M. (2003). Functional magnetic resonance imaging of 
source versus item memory. Neuroreport, 14, 2275–2281. 
Glisky, E. L., & Kong, L. L. (2008). Do young and older adults rely on different 
processes in source memory tasks? A neuropsychological study. Journal of 
Experimental Psychology: Learning, Memory, & Cognition, 34, 809–822. 
Glisky, E. L., Polster, M. R., & Routhieaux, B. C. (1995). Double dissociation between 
item and source memory. Neuropsychology, 9, 229–235. 
Glisky, E. L., Rubin, S. R., & Davidson, P. S. R. (2001). Source memory in older adults: 
An encoding or retrieval problems? Journal of Experimental Psychology: 
Learning, Memory and Cognition, 27, 1131–1146. 
Hashtroudi, S., Johnson, M. K., & Chrosniak, L. D. (1989). Aging and source 
monitoring. Psychology and Aging, 4, 106–112. 
Henkel, L. A., Johnson, M. K., & De Leonardis, D. M. (1998). Aging and source 
monitoring: Cognitive processes and neuropsychological correlates. Journal of 
Experimental Psychology: General, 127, 251–268. 
Janowsky, J. S., Shimamura, A. P., & Squire, L. R. (1989). Source memory impairment 
in patients with frontal lobe lesions. Neuropsychologia, 27, 1043–1056. 
Johnson, M. K., Hashtroudi, S., & Lindsay, D. S. (1993). Source monitoring. 
Psychological Bulletin, 114, 3–8. 
Jurica, P. J., Leitten, S., Mattis, S. (2001). Dementia Rating Scale-2: Professional 
manual. Lutz, FL: Psychological Assessment Resources. 
Kausler, D. H. (1994). Learning and memory in normal aging. Academic Press: San 
Diego, CA. 
Kirwan, C. B., Wixted, J. T., & Squire, L. R. (2008). Activity in the medial temporal lobe 
predicts memory strength, whereas activity in the prefrontal cortex predicts 
recollection. Journal of Neuroscience, 28, 10541–10548. 
Macmillan, N. A., & Creelman, D. C. (1991). Detection theory: A user’s guide. New 
York: Cambridge University Press. 
 73 
McIntyre, J. S., & Craik, F. I. M. (1987). Age difference in memory for item and source. 
Canadian Journal of Psychology, 41, 175–192. 
Mitchell, K. J., Raye, C. L., Johnson, M. K., & Greene, E. J. (2006). An fMRI 
investigation of short-term source memory in young and older adults. 
Neuroimage, 30, 627–633. 
Naveh-Benjamin, M., & Craik, F. I. (1995). Memory for context and its use in item 
memory: Comparisons of younger and older persons. Psychology and Aging, 10, 
284–293.  
Peters, J., Koch, B., Schwarz, M., & Daum, I. (2007). Domain-specific impairment of 
source memory following a right posterior medial temporal lobe lesion. 
Hippocampus, 17, 505–509. 
Schacter, D. L., Harbluk, J. L., & McLachlin, D. R. (1984). Retrieval without 
recollection: An experimental analysis of source amnesia. Journal of Verbal 
Learning and Verbal Behavior, 23, 593–611. 
Schacter, D. L., Kaszniak, A. W., Kihlstrom, J. F., & Valdiserri, M. (1991). The relation 
between source memory and aging. Psychology and Aging, 6, 559–568. 
Shimamura, A. P., & Squire, L. R. (1987). A neuropsychological study of fact memory 
and source amnesia. Journal Experimental Psychology: Learning, Memory, and 
Cognition, 13, 464–473. 
Spaniol, J., Madden, D. J., & Voss, A. (2006). A diffusion model analysis of adult age 
differences in episodic and semantic long-term memory retrieval. Journal of 
Experimental Psychology: Learning, Memory, & Cognition, 32, 101–117. 
Stark, C. E., & Squire, L. R. (2000). Functional magnetic resonance imaging (fMRI) 
activity in the hippocampal region during recognition memory. Journal of 
Neuroscience, 20, 7776–7781. 
Stark, C. E. & Squire, L. R. (2003). Hippocampal damage equally impairs memory for 
single items and memory for conjunctions. Hippocampus, 13, 281–292. 
Trott, C. T., Friedman, D., Ritter, W., Fabiani, M., & Snodgrass, J. G. (1999). Episodic 
priming and memory for temporal source: Event related potentials reveal age-
related differences in prefrontal functioning. Psychology and Aging, 14, 390–413. 
Turner, M. L., & Pinkston, R. S. (1993). Effects of a memory and aging workshop on 
negative beliefs of memory loss in the elderly. Educational Gerontology, 19(5), 
359-373. doi:10.1080/0360127930190501 
Van der Linden, M., Philippot, P., & Heinen, P. (1997). Effect of age, education and 
verbal efficiency on memory performance and memory self-assessment. Archives 
de Psychologie, 65(254), 171-185. 
 74 
Woodruff-Pak, D. S., & Finkbiner, R. G. (1995). Larger nondeclarative than declarative 
deficits in learning and memory in human aging. Psychology and Aging, 10(3), 
416-426. 
  
 75 
CHAPTER 4: 
Study 3 
The content within this section, titled “Chapter 4: Study 3,” reflects material from 
a paper that has been published in the Journal of the International Neuropsychological 
Society. The proper citation is as follows: 
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analysis on the California Verbal Learning Test-3: Clinical utility in Alzheimer’s and 
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Abstract 
Objective: The third edition of the California Verbal Learning Test (CVLT-3) 
includes a new index termed List A vs. Novel/Unrelated recognition discriminability 
(RD) on the Yes/No Recognition trial. Whereas the Total RD index incorporates false 
positive (FP) errors associated with all distractors (including List B and semantically-
related items), the new List A vs. Novel/Unrelated RD index incorporates only FP errors 
associated with novel, semantically-unrelated distractors. Thus, in minimizing levels of 
source and semantic interference, the List A vs. Novel/Unrelated RD index may yield 
purer assessments of yes/no recognition memory independent of vulnerability to source 
memory difficulties or semantic confusion, both of which are often seen in individuals 
with primarily frontal-system dysfunction (e.g., early Huntington’s disease [HD]). 
Method: We compared the performance of individuals with Alzheimer’s disease (AD) 
and HD in mild and moderate stages of dementia on CVLT-3 indices of Total RD and 
List A vs. Novel/Unrelated RD. Results: Although AD and HD subgroups exhibited 
deficits on both RD indices relative to healthy comparison groups, those with HD 
generally outperformed those with AD, and group differences were more robust on List A 
vs. Novel/Unrelated RD than on Total RD. Conclusions: Our findings highlight the 
clinical utility of the new CVLT-3 List A vs. Novel/Unrelated RD index, which (a) 
maximally assesses yes/no recognition memory independent of source and semantic 
interference; and (b) provides a greater differentiation between individuals whose 
memory disorder is primarily at the encoding/storage level (e.g., as in AD) versus at the 
retrieval level (e.g., as in early HD). 
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New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-
3: Clinical Utility in Alzheimer’s and Huntington’s Disease 
Alzheimer’s disease (AD) is associated with early medial temporal lobe damage, 
particularly in the hippocampal formation, subsequent damage to cortical association 
areas, and relative sparing of most subcortical structures (Braak & Braak, 1991; Hyman, 
Van Hoesen, Damasio, & Barnes, 1984). Huntington’s disease (HD), in contrast, is 
associated with early damage to basal ganglia structures (Vonsattel, 2000; Vonsattel et 
al., 1985) that have extensive projections to the frontal lobes (Alexander, Crutcher, & 
DeLong, 1990; Crosson et al., 2003; Cummings, 1993), followed by more diffuse 
involvement of other cortical and subcortical regions and networks. Research has shown 
that the different patterns of neurodegeneration associated with AD and HD yield distinct 
profiles of memory loss (Delis et al., 1991; Hodges, Salmon, & Butters, 1990; Moss, 
Albert, Butters, & Payne, 1986; Salmon & Bondi, 2009; Salmon & Filoteo, 2007; Troster 
et al., 1993). Individuals with AD usually have pervasive memory deficits characterized 
by poor learning, rapid forgetting, and poor recognition (Budson & Kowall, 2013), a 
profile of memory loss thought to reflect an encoding/storage deficit. Patients with early 
stage HD often have significant deficits in recall with less compromised recognition 
(Butters, Wolfe, Granholm, & Martone, 1986; Butters, Wolfe, Martone, Granholm, & 
Cermak, 1985; Lundervold, Reinvang, & Lundervold, 1994; Martone, Butters, Payne, 
Becker, & Sax, 1984; Massman, Delis, Butters, Levin, & Salmon, 1990), a profile of 
memory loss thought to reflect primarily a retrieval deficit. Although recognition is less 
impaired than recall in early HD, recognition is still often significantly impaired, 
particularly in the later stages of disease, raising the possibility that encoding processes 
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are also compromised to at least some degree (see Montoya et al., 2006 for review). 
Given that the prefrontal cortex has been shown to be implicated in encoding processes 
(e.g., Blumenfeld & Ranganath, 2007; Tulving et al., 1994) and that HD is associated 
with frontal system pathology and dysfunction, the extent to which encoding is affected 
in HD may at least partly depend on the degree to which prefrontal networks become 
compromised throughout the disease process. Nonetheless, it is unlikely that encoding 
deficits in HD would ever reach a level of severity comparable to what is observed in 
AD, given the disproportionately greater impact of AD on medial temporal regions that 
play a more integral role in encoding processes. Rather, the pattern of memory 
dysfunction in HD is likely best characterized as primarily a retrieval deficit, even when 
accompanied by mild encoding difficulties. 
In efforts to characterize profiles of memory loss, the degree to which recognition 
memory is affected provides insight into whether impaired recall reflects (a) failure to 
encode/store information at the outset (i.e., an encoding/storage deficit, as in AD), or (b) 
compromised retrieval processes that warrant prompting or cuing to facilitate recognition 
of previously encoded information (i.e., a retrieval deficit, as in early HD). Although the 
extant literature suggests that a major distinction between the memory profiles associated 
with AD and with HD largely involves the extent to which recognition memory is 
impaired, the nature and degree to which it is affected in HD in particular is less clear and 
warrants further exploration.  
CVLT Studies of Yes/No Recognition Memory in AD and HD 
The California Verbal Learning Test (CVLT) is a list-learning measure that 
assesses a multitude of verbal learning and memory indices, including immediate recall, 
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free and cued recall over short and long delays, and Yes/No Recognition. Studies using 
the original CVLT (Delis, Kramer, Kaplan, & Ober, 1987) consistently demonstrated that 
among individuals in mild stages of dementia, deficits on the Yes/No Recognition trial 
are less severe in those with HD than in those with AD (Delis et al., 1991; Kramer et al., 
1988; Kramer, Levin, Brandt, & Delis, 1989). This difference was shown with the 
original CVLT recognition discriminability (RD) index that measures the ability to 
distinguish List A targets from all distractors on the Yes/No Recognition trial (Delis et 
al., 1991; Kramer et al., 1988). In contrast, studies that compared individuals with AD or 
HD on the Yes/No Recognition trial of the second edition of the CVLT (CVLT-II; Delis, 
Kramer, Kaplan, & Ober, 2000) have produced inconsistent results. While one study 
found that individuals with HD obtained higher standardized scores than those with AD 
on the CVLT-II Total RD index (Fine et al., 2008), another study with a larger sample 
found that AD and HD groups performed comparably on this measure (Graves et al., 
2017). One implication of this pattern of results is that patients with HD may have worse 
Yes/No Recognition performance on the CVLT-II than on the original CVLT. This 
possibility is consistent with the clinical observation that Total RD scores of patients with 
HD are generally lower on the CVLT-II than on the original CVLT (Dean C. Delis, 
personal communication, October 26, 2017). 
Reasons for differences in the performance of individuals with HD on the 
recognition components of the two versions of the CVLT may lie in differences in how 
RD is determined. The Yes/No Recognition trial of the original CVLT included only half 
(i.e., eight) of the 16 List B items as distractors (Delis et al., 1987). Due to a ceiling effect 
in cognitively normal individuals, the trial’s difficulty was increased in the CVLT-II by 
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including all 16 List B items as distractors (Dean C. Delis, personal communication, 
September 26, 2017). Although this had the intended effect of making the Yes/No 
Recognition trial more difficult, it potentially made the test more sensitive to deficits in 
source memory. Individuals with frontal-system dysfunction (e.g., HD) may have 
particular difficulty in identifying the source of each previously-presented item (List A or 
List B) during the Yes/No Recognition trial when asked whether or not an item had been 
on List A (Fine et al., 2008). Increasing the number of List B distractors on the CVLT-II 
Yes/No Recognition trial may have amplified this difficulty.   
The CVLT-II Yes/No Recognition trial also had an increased proportion of 
distractors that are semantically-related to List A target items (8 of 28 distractors for 
CVLT versus 16 of 32 distractors for CVLT-II; Delis et al., 2000). Research has shown 
that patients with frontal-system dysfunction are prone to making semantic intrusion or 
semantic confusion errors due to impaired inhibition of activation within semantic 
networks (e.g., Baldo et al., 2002). A deficit in inhibition of the semantic network during 
the CVLT may lead individuals with HD to have greater difficulty in rejecting distractors 
that share obvious semantic associations with targets than in rejecting distractors that do 
not (the same deficit could lead to semantically-related intrusion errors during free recall 
trials). This would have a greater adverse effect on the CVLT-II than the CVLT for 
individuals with HD due to the increased proportion of semantically-related distractors. 
Increasing the proportion of semantically-related distractors may not have the same effect 
on individuals with AD since their severe recognition memory deficits reflect a profound 
encoding/storage deficit that can be attributed to more extensive neuropathology targeting 
the medial temporal lobes and cortical association areas. Thus, individuals with AD are 
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likely to exhibit relatively comparable levels of difficulty in rejecting novel distractors 
whether or not they share obvious semantic associations with targets.  
A Purer Sub-Measure of Novel RD on the CVLT-3 
While the CVLT-II included eight novel unrelated distractor items on the Yes/No 
Recognition trial, it did not provide a separate index that assessed the ability of 
individuals to endorse List A targets while rejecting those novel unrelated distractors. 
The second and third editions of the CVLT (CVLT-II and CVLT-3, respectively) contain 
the same target words on the recall trials and the same targets and distractors on the 
Yes/No Recognition trial (in fact, the only word-item changes that were made to the 
CVLT-3 are on the Forced Choice Recognition trial). However, the CVLT-3 (Delis, 
Kramer, Kaplan, & Ober, 2017) includes a purer RD index, List A vs. Novel/Unrelated 
RD, that isolates the ability to distinguish List A targets from distractors that were not 
previously presented during test administration and do not share obvious semantic 
associations with targets. Thus, the new List A vs. Novel/Unrelated RD index minimizes 
any potential influences of source and semantic interference, and is therefore thought to 
provide a more refined assessment of yes/no recognition memory.  
The present study sought to elucidate the nature of AD and HD differences in 
yes/no recognition memory by comparing the performance of individuals with AD and 
HD in mild and moderate stages of dementia on CVLT-3 indices of Total RD and List A 
vs. Novel/Unrelated RD. It was hypothesized that although both AD and HD would be 
associated with deficits on Yes/No Recognition testing, individuals with HD would 
perform better than those with AD, particularly on the new List A vs. Novel/Unrelated 
RD index. In other words, the List A vs. Novel/Unrelated RD index, in minimizing any 
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potential influences of source and semantic interference, was expected to exhibit greater 
utility than the Total RD index in distinguishing the memory profiles of individuals with 
AD versus HD. 
Method 
Participants 
Study participants were 52 individuals with AD, 55 individuals with HD, 53 
healthy older adults (OA), and 31 healthy middle-age adults (MA); the healthy OA and 
MA groups were included to serve as AD and HD comparison groups, respectively. The 
Dementia Rating Scale (DRS) or the Dementia Rating Scale-2 (DRS-2; Jurica, Leitten, & 
Mattis, 2001) was administered to individuals in the AD and HD subgroups to provide an 
assessment of global cognitive functioning. Individuals with AD and HD were 
characterized as mild or moderate in dementia severity based on DRS/DRS-2 scores: 
120+ = mild, 100-119 = moderate (mod). Accordingly, the study sample consisted of six 
total groups, with 25 Alzheimer’s disease-mild (AD-mild), 27 Alzheimer’s disease-
moderate (AD-mod), 39 Huntington’s disease-mild (HD-mild), 16 Huntington’s disease-
moderate (HD-mod), 53 OA, and 31 MA participants. Individuals with AD were 
recruited from the Shiley-Marcos Alzheimer’s Disease Research Center (ADRC) 
affiliated with the University of California, San Diego (UCSD). Diagnoses of individuals 
with probable AD were made by a senior staff neurologist at the ADRC and were 
consistent with the criteria established by the National Institute of Neurological and 
Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders 
Association (ADRDA) workgroups (McKhann et al., 1984; McKhann et al., 2011).  
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Individuals with HD were recruited from the Huntington’s Disease Clinical 
Research Center (HDCRC) at UCSD and were administered the Unified Huntington’s 
Disease Rating Scale (UHDRS; Huntington Study Group, 1996) by a senior staff 
neurologist. Individuals with HD were diagnosed with definite HD on the basis of 
unequivocal motor signs on the UHDRS and a positive family history of HD. Participants 
in the HD-mild group had an average Total Motor Score (TMS) of 34.89 (SD = 14.24), 
and participants in the HD-mod group had an average TMS of 50.00 (SD = 16.94), with 
higher scores indicating greater severity of motor symptoms. In addition, all HD 
participants had a CAG repeat length greater than 39, indicating that all carried the fully 
penetrant genetic mutation for HD. Participants in the HD-mild group had an average of 
44.57 (SD = 3.48) CAG repeats, and participants in the HD-mod group had an average of 
45.88 (SD = 4.30) CAG repeats. Portions of the AD and HD groups in the present study 
overlap with the samples used in previous studies (Delis et al., 2005; Fine et al., 2008; 
Graves et al., 2017). Exclusionary criteria for AD and HD participants included the 
following: a diagnosis of any neurological disorder aside from AD or HD, respectively; a 
diagnosis of any major medical condition (e.g., cancer); a diagnosis of any major 
psychiatric disorder (with the exception of a mood or anxiety disorder for which any 
current symptoms must have been well managed); a history of traumatic brain injury; and 
a history of a substance use disorder. Whether participants with AD or HD met 
exclusionary criteria was determined based on information gathered via a combination of 
self-report, informant-report, and medical records. 
Healthy OA participants were recruited from the San Diego community by the 
Center for Healthy Aging and Neurodegenerative Disease Research (CHANDR) at San 
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Diego State University (SDSU) directed by P. E. G. and the Normal Aging Laboratory at 
UCSD directed by M. W. B. Healthy MA participants were recruited from the San Diego 
community by the CHANDR directed by P. E. G. and the HDCRC directed by J. C. B. 
Exclusionary criteria for all healthy adult participants included the following: a diagnosis 
of any neurological disorder, a diagnosis of any major medical condition (e.g., cancer), a 
diagnosis of any major psychiatric disorder (with the exception of a mood or anxiety 
disorder, for which any current symptoms must have been well managed), a history of 
traumatic brain injury, and a history of a substance use disorder. Whether OA and MA 
participants met exclusionary criteria was determined based on information gathered 
primarily via self-report. 
CVLT-II data were extracted from archival databases that included data from a 
larger battery of neuropsychological tests administered by trained research assistants or 
psychometrists at the ADRC, HDCRC, CHANDR, and Normal Aging Laboratory. All 
participants provided informed written consent and the study was approved by the 
Institutional Review Board of SDSU and/or UCSD.  
CVLT-II and Yes/No Recognition Indices 
 The CVLT-II is a list-learning test that provides a multitude of verbal learning 
and memory indices, including immediate recall, free and cued recall over short and long 
delays, and Yes/No Recognition. The CVLT-II was administered using standard 
procedures outlined by Delis and colleagues (2000). Short- and long-delay tests of recall 
were separated by an interval of approximately 20 minutes, during which other nonverbal 
neuropsychological measures were administered.  
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Given that the CVLT-II and CVLT-3 contain identical target words on the recall trials 
and identical targets and distractors on the Yes/No Recognition trial, CVLT-3 algorithms 
were applied to CVLT-II data to generate scores on variables of interest in the present 
study: Total RD and List A vs. Novel/Unrelated RD. Raw d’ scores on Total RD and List 
A vs. Novel/Unrelated RD indices were calculated using methods employed on all three 
versions of the CVLT (Delis et al., 1987; Delis et al., 2000; Delis et al., 2017) that are 
based on signal detection theory (see Macmillan & Creelman, 1991). In general, d’ = 
z(hit rate) – z(FP rate), and raw d’ scores on the Total RD and List A vs. Novel/Unrelated 
RD indices are therefore generated using the following formulas: 
1. Total RD = z(Total Hit rate) – z(Total FP rate) 
2. List A vs. Novel/Unrelated RD = z(Total Hit rate) – z(Novel/Unrelated FP 
rate) 
The hit rate refers to the proportion of targets endorsed and the FP rate refers to the 
proportion of distractors endorsed. A z-transform is applied to each hit rate and FP rate, 
and subtracting the latter from the former yields d’. Thus, as the CVLT-3 manual (Delis 
et al., 2017) states, the raw d’ score reflects the difference in standard deviation (SD) 
units between the examinee’s hit rate (signal) and FP rate (noise). For instance, if the hit 
rate is 84% of the possible targets (approximately one SD above the expected mean) and 
the FP rate is 16% of the possible distractors (approximately one SD below the expected 
mean), the raw d’ score is approximately +2.0. In contrast, if the hit rate is 16% and the 
FP rate is 84%, the raw d’ score is approximately -2.0. If the hit rate and FP rate are both 
at 50% accuracy, then d’ is 0. While the range of raw d’ scores will vary depending on 
the number of FP errors, Total RD on the CVLT-3 can range from a high of +4.0 (16 hits, 
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0 FP errors) to a low of -4.0 (0 hits, 32 FP errors). Scaled scores on Total RD and List A 
vs. Novel/Unrelated RD indices were derived using the CVLT-3 standardization sample 
norms that adjust for age and gender. 
Statistical Analyses 
Analyses were conducted in the Statistical Package for the Social Sciences 
(SPSS) Version 25.  
Demographic and preliminary analyses. Prior to conducting primary analyses, 
one-way analysis of variance (ANOVA) tests (with Tukey’s post-hoc pairwise 
comparisons) and chi-square analyses were conducted to examine group differences on 
demographic variables, including age, gender, and education, as well as DRS/DRS-2 
scores. Additionally, preliminary ANOVA and ANCOVA tests were conducted to 
determine whether any demographic variables were significant predictors of raw scores 
on Yes/No Recognition variables of interest.  
Primary analyses. ANCOVA tests were conducted to examine the effect of 
group (AD-mod, AD-mild, HD-mod, HD-mild, OA, MA) on raw scores on Total RD and 
List A vs. Novel/Unrelated RD indices, while controlling for demographic factors when 
appropriate. Additionally, ANOVA tests were conducted to examine the effect of group 
on scaled scores on Total RD and List A vs. Novel/Unrelated RD indices. Post-hoc 
pairwise comparisons were conducted to examine group differences on raw and scaled 
scores on Total RD and List A vs. Novel/Unrelated RD indices in the context of 
significant group effects. The following comparisons were of primary interest and are 
emphasized in the discussion of results and their implications: 1) AD-mod versus HD-
mod, 2) AD-mild versus HD-mild, 3) AD-mod versus AD-mild, 4) HD-mod versus HD-
 88 
mild, 5) AD-mod versus HD-mild, and 6) AD-mild versus HD-mod. The Bonferroni 
adjustment applied to this set of comparisons was:  = .05/6 = .008. Cohen’s d effect size 
values associated with significant AD and HD group differences were calculated and 
reported. In addition, the following comparisons were conducted to provide information 
regarding the level of performance that may be expected among cognitively healthy 
groups relative to demographically similar but clinically impaired AD and HD groups on 
the new CVLT-3 List A vs. Novel/Unrelated index: 1) AD-mod versus OA, 2) AD-mild 
versus OA, 3) HD-mod versus MA, and 4) HD-mild versus MA. The Bonferroni 
adjustment applied to this set of comparisons was:  = .05/4 = .013.  
Exploratory analyses. Regression analyses were conducted to explore whether 
TMS scores and number of CAG repeats were significant predictors of raw scores on 
Total RD and List A vs. Novel/Unrelated RD indices in participants with HD. 
Exploratory analyses involving participants with AD could not be conducted, as clinical 
data were not available on these individuals. 
Results 
Demographic Analyses 
Demographic information on study participants is provided in Table 1. One-way 
ANOVA tests revealed a significant effect of group on age, F(5, 185) = 109.05, p < .001, 
education, F(5, 185) = 5.04, p < .001, and DRS/DRS-2 scores, F(3, 103) = 114.35, p < 
.001. Tukey’s post-hoc pairwise comparisons revealed that, as expected, the AD-mild, 
AD-mod, and OA groups were significantly older than the HD-mild, HD-mod, and MA 
groups (ps < .001). However, there were no differences in age among the AD-mod, AD-
mild, and OA groups (ps > .05), or among the HD-mod, HD-mild, and MA groups (ps > 
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.05). In addition, Tukey’s post-hoc pairwise comparisons revealed that the OA group 
completed significantly more years of education than the HD-mild, HD-mod, and MA 
groups (ps < .05). However, there were no differences in education among the AD-mild, 
AD-mod, HD-mild, and HD-mod groups (ps > .05); among the AD-mild, AD-mod, and 
OA groups (ps > .05); or among the HD-mild, HD-mod, and MA groups (ps > .05). 
Furthermore, Tukey’s post-hoc pairwise comparisons revealed that, as expected, the AD-
mod and HD-mod groups had significantly lower DRS/DRS-2 scores than the AD-mild 
and HD-mild groups (ps < .001). However, there were no differences in DRS/DRS-2 
scores between the AD-mod and HD-mod groups (p > .05), or between the AD-mild and 
HD-mild groups (p > .05). The chi-square analysis revealed no differences in gender 
distributions across groups, 2 (5, N = 191) = 9.52, p = .09. 
Preliminary Analyses 
 Age was shown to be a significant predictor of raw scores on the Total RD index, 
F(1, 189) = 3.74, p < .05, but not the List A vs. Novel/Unrelated RD index, F(1, 189) = 
2.59, p = .11. Given the evidence for significant group differences on age, and for a 
significant effect of age on aspects of Yes/No Recognition performance, age was 
included as a covariate in all primary analyses involving raw scores. As scaled scores 
correct for age, age was not included as a covariate in any primary analyses involving 
scaled scores.  
Gender was shown to be a significant predictor of raw scores on the Total RD 
index, F(1, 189) = 3.87, p < .05, but not the List A vs. Novel/Unrelated RD index, F(1, 
189) = 1.29, p = .26. Although gender distributions did not vary significantly across 
groups, gender was controlled for in all primary analyses involving raw scores given the 
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evidence for a significant effect of gender on aspects of Yes/No Recognition 
performance. As scaled scores correct for gender, gender was not controlled for in any 
primary analyses involving scaled scores.  
DRS/DRS-2 scores were shown to be a significant predictor of raw scores on the 
Total RD index, F(1, 105) = 25.85, p < .001, and the List A vs. Novel/Unrelated RD 
index, F(1, 105) = 18.41, p < .001. However, given that DRS/DRS-2 scores were 
systematically varied by group (i.e., individuals with AD and HD were characterized as 
mild or moderate in dementia severity), DRS/DRS-2 scores were not controlled for in 
primary analyses involving raw or scaled scores. Education was not shown to be a 
significant predictor of raw scores on Yes/No Recognition variables of interest (ps > .05). 
Primary Analyses: AD and HD Performances on Total RD and List A vs. 
Novel/Unrelated RD Indices  
 ANCOVA tests revealed a significant effect of group on raw scores on the Total 
RD index, F(5, 183) = 71.88, p < .001, and the List A vs. Novel/Unrelated RD index, 
F(5, 183) = 39.86, p < .001, controlling for age and gender. Post-hoc tests with 
Bonferroni adjustments for multiple comparisons revealed that, on both indices, the AD-
mild and AD-mod groups exhibited significantly lower raw scores than the OA group (ps 
< .001), and the HD-mild and HD-mod groups exhibited significantly lower raw scores 
than the MA group (ps < .001). Additionally, the HD-mild group exhibited significantly 
higher raw scores than the AD-mild and AD-mod groups on both indices (ps < .01). 
Furthermore, the HD-mod group exhibited significantly higher raw scores than the AD-
mod group on the List A vs. Novel/Unrelated RD index (p = .001), although this 
difference was not observed on the Total RD index (after a Bonferroni adjustment). No 
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other significant group differences on raw scores on the Total RD and List A vs. 
Novel/Unrelated RD indices were observed. 
ANOVA tests also revealed a significant effect of group on scaled scores on the 
Total RD index, F(5, 185) = 66.68, p < .001, and the List A vs. Novel/Unrelated RD 
index, F(5, 185) = 41.16, p < .001. Post-hoc tests with Bonferroni adjustments for 
multiple comparisons revealed that, on both indices, the AD-mild and AD-mod groups 
exhibited significantly lower scaled scores than the OA group (ps < .001), and the HD-
mild and HD-mod groups exhibited significantly lower scaled scores than the MA group 
(ps < .001). Additionally, the HD-mild group exhibited significantly higher scaled scores 
than the AD-mod group on the List A vs. Novel/Unrelated RD index (p = .001), although 
this difference was not observed on the Total RD index (after a Bonferroni adjustment). 
No other significant group differences on scaled scores on the Total RD and List A vs. 
Novel/Unrelated RD indices were observed. 
Descriptive and inferential statistics associated with analyses involving raw and 
scaled scores on the Total RD and List A vs. Novel/Unrelated RD indices are provided in 
Tables 2 and 3. Relevant group differences on raw and scaled scores on the two indices 
are illustrated in Figures 1 and 2. 
Exploratory analyses. Regression analyses indicated neither TMS scores nor 
number of CAG repeats were significant predictors of raw scores on Total RD or List A 
vs. Novel/Unrelated RD indices in participants with HD (ps > .05). 
Discussion 
The present study compared the performance of individuals with AD and HD in mild and 
moderate stages of dementia on indices of Total RD and List A vs. Novel/Unrelated RD 
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that were developed for the CVLT-3. Group differences on RD indices involving the AD-
mod, AD-mild, HD-mod, and HD-mild groups were of primary interest; however, OA 
and MA groups were included as cognitively healthy comparison groups for AD and HD, 
respectively. Because the CVLT-3 List A vs. Novel/Unrelated index is a new measure, 
the OA and MA groups were included in analyses of scaled scores, in addition to raw 
scores, to provide information regarding the level of scaled score performance that might 
be expected from cognitively healthy individuals demographically similar to clinically 
impaired patients with AD or HD. Results showed that all AD and HD subgroups 
performed significantly worse than their respective healthy comparison groups on all 
Yes/No Recognition RD raw scores and scaled scores. 
Analysis of raw scores on Yes/No Recognition indices showed that the HD-mild 
group performed significantly better than the AD-mod and AD-mild groups on both the 
Total RD and List A vs. Novel/Unrelated RD indices. Additionally, the HD-mod group 
performed significantly better than the AD-mod group on the List A vs. Novel/Unrelated 
RD index; notably, this difference was not observed on the Total RD index. These 
findings demonstrate that, in the context of raw scores, both the Total RD and List A vs. 
Novel/Unrelated RD indices are able to reveal less severe yes/no recognition memory 
deficits in mild HD than in mild AD. Importantly, however, as predicted, the List A vs. 
Novel/Unrelated RD index, but not the Total RD index, yielded less severe yes/no 
recognition memory deficits in moderate HD than in moderate AD. The flowchart below 
outlines the pattern of HD and AD performance that may be expected with raw scores on 
the CVLT-3 Total RD and List A vs. Novel/Unrelated RD indices, and may serve as a 
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helpful reference for clinicians and researchers when using the CVLT-3 to assess Yes/No 
Recognition performance in individuals with HD or AD. 
Analysis of scaled scores on Yes/No Recognition indices showed no group 
differences among the AD and HD subgroups on the Total RD index. This is consistent 
with previous findings of comparable performance by individuals with AD or HD on the 
CVLT-II Total RD index (Graves et al., 2017), and extends earlier findings by showing 
comparable performance on the Total RD index in AD and HD across mild and moderate 
stages of dementia severity. Importantly, the HD-mild group performed significantly 
better than the AD-mod group on the scaled score for the List A vs. Novel/Unrelated RD 
index. Thus, even in the context of scaled scores (albeit to a lesser extent than in the 
context of raw scores), AD and HD differences on yes/no recognition memory are 
detectable, but only using a purer index of RD that minimizes potential influences of 
source and semantic interference (i.e., List A vs. Novel/Unrelated RD).  
The discrepancy between findings from analyses involving raw scores and those 
involving scaled scores warrants discussion. First, we acknowledge that the difference 
may have been partly due to limited statistical power, given the relatively small number 
of participants in the HD-mod group in particular. However, we believe the discrepancy 
more likely reflects an issue in converting raw scores into scaled scores on indices with 
potential ceiling effects. Given that most cognitively normal individuals are expected to 
perform well on these RD indices (particularly on List A vs. Novel/Unrelated RD), lower 
raw scores in cognitively impaired individuals (e.g., the participants with AD or HD in 
our study) are likely to correspond with significantly reduced scaled scores. In addition, 
while we treated age as a continuous variable in our analyses of raw scores, the CVLT-3 
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normative sample was stratified into age groups, and age-corrected scaled scores are 
derived from these categorical groupings. Moreover, given that individuals with HD are 
younger, on average, than individuals with AD, raw scores in those with HD may be 
submitted to a more stringent age correction, which could further result in smaller HD 
and AD differences in the context of scaled scores relative to raw scores. On that 
premise, it is worth noting that, when analyzing raw scores, including age as a covariate 
when age is confounded with group or diagnosis is not the most ideal method for 
parceling out the effects of age on performance, and this is an inherent issue in many 
studies comparing AD and HD performance using raw scores. Moreover, we did not 
possess the statistical power that would be required to account for age using more 
sophisticated statistical methods (e.g., stratification). We encourage readers to take these 
issues into consideration in the evaluation of the present findings. Nonetheless, due to the 
aforementioned reasons, we believe that examining performance using raw scores 
(controlling for age as a continuous variable albeit its limitations) may yield greater 
sensitivity and better reflect the utility of the CVLT-3 RD indices in elucidating the 
degree to which yes/no recognition memory is impaired in HD versus AD.  
Taken together, the present results with both raw and scaled scores indicate that 
the new CVLT-3 List A vs. Novel/Unrelated RD index has a more robust capacity than 
the Total RD index to detect differences in the recognition memory deficits associated 
with AD and HD. In particular, the present findings suggest that recognition memory 
deficits are less severe in HD than in AD and support the notion that the memory profile 
of HD reflects primarily a retrieval deficit, whereas the memory profile of AD reflects a 
more profound encoding/storage deficit. The Total RD index incorporates FP errors from 
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all distractor types (including those from List B and those that are novel but share 
obvious semantic associations with targets), whereas the List A vs. Novel/Unrelated RD 
index incorporates only FP errors associated with distractors that are novel and do not 
share obvious semantic associations with targets. Thus, the present findings provide 
evidence that individuals with HD may be particularly vulnerable to 1) endorsing List B 
distractors that are likely confounded by source interference, and 2) endorsing novel 
distractors that share obvious semantic associations with targets and are therefore likely 
confounded by semantic interference. Accordingly, those with HD may perform more 
similarly to individuals with AD on the Total RD index due to source memory deficits 
and semantic interference sensitivity associated with their frontal-system dysfunction. 
The present findings also support the hypothesis of Graves et al. (2017) that the higher 
proportion of List B and semantically related distractors relative to targets on the CVLT-
II than on the original CVLT may have increased the difficulty of the CVLT-II Yes/No 
Recognition trial specifically for individuals with HD, thereby making their performance 
on the CVLT-II Total RD index similar to that of individuals with AD. 
In conclusion, the present findings provide evidence that the endorsement of 
distractors on Yes/No Recognition testing may be influenced by both 1) their novelty 
(i.e., whether or not they were previously presented during test administration), and 2) 
their degree of semantic association with targets. While it is probably not feasible to 
develop an RD index that is completely free of any influences of source and/or semantic 
interference, the present findings indicate that the new CVLT-3 List A vs. 
Novel/Unrelated RD index minimizes these effects compared to the Total RD index. 
Thus, while the Total RD index provides a global, more sensitive measure of yes/no 
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recognition memory in general, the new List A vs. Novel/Unrelated RD index likely 
provides a purer measure of yes/no recognition memory independent of source and 
semantic interference, and may therefore exhibit greater utility in differentiating levels of 
yes/no recognition memory impairment in HD versus AD. 
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Figures 
 
 
Figure 4.1. Mean (standard error) raw scores on the Total RD and List A vs. 
Novel/Unrelated RD indices in the Alzheimer’s disease-moderate (AD-mod), Alzheimer’s 
disease-mild (AD-mild), Huntington’s disease-moderate (HD-mod), and Huntington’s 
disease-mild (HD-mild) groups. 
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Figure 4.2. Mean (standard error) scaled scores on the Total RD and List A vs. 
Novel/Unrelated RD indices in the Alzheimer’s disease-moderate (AD-mod), Alzheimer’s 
disease-mild (AD-mild), Huntington’s disease-moderate (HD-mod), and Huntington’s 
disease-mild (HD-mild) groups. 
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Figure 4.3. Flowchart outlining the pattern of performance that may be expected with 
raw scores on the CVLT-3 Total RD and List A vs. Novel/Unrelated RD indices in 
Huntington’s disease and Alzheimer’s disease. 
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Tables 
 
Table 4.1. Demographic information on participants in the Alzheimer’s disease-moderate 
(AD-mod), Alzheimer’s disease-mild (AD-mild), Huntington’s disease-moderate (HD-
mod), Huntington’s disease-mild (HD-mild), healthy older adult (OA), and healthy 
middle-aged adult (MA) groups. 
 
  
Variable AD-mod AD-mild HD-mod HD-mild OA MA
n 27 25 16 39 53 31
% Female 33.33 40.00 56.25 66.67 47.17 58.06
78.67 (5.02) 75.28 (4.84) 49.38 (11.93) 49.87 (11.67) 74.57 (6.38) 48.90 (4.53)
67-85 65-84 25-73 34-78 65-89 41-55
15.22 (3.39) 15.44 (2.89) 14.13 (2.28) 14.18 (2.33) 16.30 (2.09) 14.19 (1.97)
6-20 9-20 12-20 8-20 12-20 10-18
112.70 (4.11) 126.88 (3.79) 112.38 (6.47) 129.74 (4.02)
101-119 120-136 100-119 121-138
Note: For age, education, and DRS/DRS-2 Total variables, first row includes mean (standard deviation) values and second 
row includes range.
Age
Education
DRS/DRS-2 Total -- --
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Table 4.2. Mean (standard deviation) values for the Alzheimer’s disease-moderate (AD-
mod), Alzheimer’s disease-mild (AD-mild), Huntington’s disease-moderate (HD-mod), 
Huntington’s disease-mild (HD-mild), healthy older adult (OA), and healthy middle-aged 
adult (MA) groups on raw and scaled scores on Total RD and List A vs. Novel/Unrelated 
RD indices, as well as RD index components. 
 
  
Variable AD-mod AD-mild HD-mod HD-mild OA MA
RD Indices
Total RD (Raw) 0.64 (0.65) 0.92 (0.67) 1.30 (0.77) 1.77 (0.82) 3.07 (0.76) 3.21 (0.59)
List A vs. Novel/Unrelated RD (Raw) 1.28 (1.09) 1.78 (1.12) 2.14 (1.10) 2.47 (0.76) 3.50 (0.56) 3.55 (0.52)
Total RD (Scaled) 4.11 (2.21) 4.52 (2.20) 4.31 (2.09) 5.80 (2.57) 12.02 (3.01) 10.42 (2.31)
List A vs. Novel/Unrelated RD (Scaled) 3.74 (3.11) 4.92 (4.02) 5.56 (3.69) 6.31 (3.16) 11.83 (2.83) 11.10 (2.36)
RD Index Components
Hits 11.11 (2.99) 11.64 (3.09) 10.31 (3.91) 12.41 (2.87) 14.74 (1.46) 14.94 (1.34)
List B FP Errors 8.63 (3.16) 7.88 (3.63) 4.56 (3.93) 3.44 (3.50) 1.68 (1.98) 0.94 (1.26)
Novel/Prototypical FP Errors 4.19 (1.88) 4.00 (2.52) 2.31 (1.85) 3.21 (2.22) 0.66 (1.41) 0.77 (1.06)
Novel/Unrelated FP Errors 2.78 (2.14) 1.80 (2.10) 0.69 (1.62) 0.67 (0.98) 0.08 (0.27) 0.10 (0.30)
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Table 4.3. p values associated with relevant pairwise comparisons on raw scores 
(controlling for age) and scaled scores on Total RD and List A vs. Novel/Unrelated RD 
indices. Cohen's d values associated with significant AD and HD group differences are 
reported. 
 
  
p d p d p d p d
AD-mod vs. HD-mod .027 -- .001* 0.79 .802 -- .066 --
AD-mild vs. HD-mild .001* 1.14 .001* 0.72 .051 -- .085 --
AD-mod vs. AD-mild .176 -- .023 -- .562 -- .175 --
HD-mod vs. HD-mild .035 -- .190 -- .050 -- .423 --
AD-mod vs. HD-mild <.001* 1.53 <.001* 1.27 .009 -- .001* 0.82
AD-mild vs. HD-mod .168 -- .062 -- .799 -- .521 --
*p value retains signficance following Bonferroni adjustment for multiple comparisons
Total RD (Raw)
List A vs. 
Novel/Unrelated RD 
(Raw)
Total RD (Scaled)
List A vs. 
Novel/Unrelated RD 
(Scaled)Comparison
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CHAPTER 5: 
Integrated Summary 
With the expanding older population in the U.S., the burden of cognitive decline 
in older age and the prevalence of dementia due to neurodegenerative disease are 
expected to increase. Given that memory loss is a hallmark feature of cognitive 
impairment in both healthy aging and dementia, more refined measures of memory are 
needed to further elucidate the nature of memory changes that may accompany normal 
aging and neurodegenerative processes. Collectively, the three studies that were proposed 
and completed in this staple dissertation project utilized innovative psychometric 
approaches to explore age-related differences on more nuanced aspects of yes/no 
recognition memory, as well as enhance the characterization of and differentiation 
between profiles of yes/no recognition memory impairment in AD and HD. 
Study 1 examined whether AD and HD differences on Total RD varied across 
applications of nonparametric and parametric formulas for calculating Total RD, and 
included an emphasis on exploring the extent to which each formula captures high FP 
error rates. Key findings indicated that relative to the AD group, the HD group exhibited 
comparable standardized parametric Total RD scores (despite higher raw nonparametric 
and parametric Total RD scores), whereas the previous CVLT literature had shown that 
standardized Total RD scores were higher in HD than in AD. Notably, analyses revealed 
that FP error rates were more strongly correlated with raw nonparametric Total RD 
scores than with raw parametric Total RD scores in the AD group, although this was not 
observed in the HD group. These observations suggested that the nonparametric Total 
RD formula may more fully capture the contribution of FP errors to a Total RD score 
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and, as a result, provide important information regarding an examinee’s recognition 
memory that may otherwise be lost in the application of the parametric Total RD formula 
and subsequent standardization of parametric Total RD scores. Thus, standardized 
parametric Total RD scores may be somewhat overestimated (i.e., the impact of high FP 
error rates on Total RD scores may be inadvertently reduced) in individuals with AD, 
which may have led in part to the observation that the HD and AD groups performed 
comparably on this index. Furthermore, these findings highlighted the importance and 
utility of examining other yes/no recognition memory indices (e.g., FP error rates, 
nonparametric Total RD) in addition to standardized parametric Total RD scores when 
using the CVLT-II to assess and characterize yes/no recognition memory. 
Given that Study 1 findings highlighted the important role of FP errors in the 
assessment of RD, Study 2 investigated the utility of refined RD indices that correspond 
to the four FP error subtypes on the CVLT-II Yes/No Recognition trial (prototypical List 
B, unrelated List B, prototypical novel, and unrelated novel) in characterizing nuanced 
aspects of yes/no recognition memory in healthy older and young adults. An emphasis 
was made on the utility of Source and Novel RD indices that isolated the ability to 
distinguish List A targets from List B and novel distractors that do not share strong 
semantic associations with targets, relative to original indices that incorporate FP errors 
associated with both prototypical and semantically-unrelated distractors, in distinguishing 
healthy older and young adults. Although older adults performed worse than young adults 
on all RD indices, key findings indicated that age group differences were smaller in 
magnitude on refined Source and Novel RD indices that exclude FP errors associated 
with semantically-related distractors relative to indices that include FP errors associated 
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with both prototypical and semantically-unrelated distractors. Moreover, older adults, but 
not young adults, performed disproportionately worse on Source RD than on Novel RD 
in the context of refined indices, providing further evidence for disproportionate age-
related decline in source memory relative to item memory. Study 2 findings suggested 
that although CVLT-II indices of Source and Novel RD in their current form are useful in 
characterizing age-related differences on aspects of yes/no recognition memory that 
pertain to source and item memory, the more refined indices may further elucidate the 
degree of between- and within-group differences on these constructs. Overall, Study 2 
findings highlight the utility of refined RD indices in characterizing yes/no recognition 
memory changes associated with healthy aging. 
The discrepancy of findings from Study 1 and those previously reported in the 
CVLT and CVLT-II literature on yes/no recognition memory in AD and HD (e.g., Fine et 
al., 2008) highlighted the need for more refined RD indices to enhance the 
characterization of and differentiation between profiles of memory loss in AD and HD. 
Whereas the Total RD index incorporates FP errors associated with all distractor types 
(including List B and semantically-related items), the new List A vs. Novel/Unrelated RD 
index on the CVLT-3 incorporates only FP errors associated with novel, semantically-
unrelated distractors. Thus, in minimizing levels of source and semantic interference, List 
A vs. Novel/Unrelated RD may yield a purer assessment of yes/no recognition memory 
that is less subject to source memory difficulties or semantic confusion, both of which are 
often seen in individuals with primarily frontal-system dysfunction (e.g., early HD). 
Study 3 sought to elucidate the nature and extent of AD and HD differences in yes/no 
recognition memory by examining performances in individuals with AD and those with 
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HD on CVLT-3 indices of Total RD and List A vs. Novel/Unrelated RD. Although the 
AD and HD groups were impaired on both RD indices relative to healthy comparison 
groups, key findings indicated that those with HD generally outperformed those with AD, 
and group differences were more robust on the new List A vs. Novel/Unrelated RD index 
than on the Total RD index. Thus, Study 3 findings highlighted that the new CVLT-3 List 
A vs. Novel/Unrelated RD index (a) maximally assesses yes/no recognition memory 
independent of source and semantic interference; and (b) provides greater differentiation 
between individuals whose memory disorder is primarily at the encoding/storage level 
(e.g., as in AD) versus at the retrieval level (e.g., as in early HD). 
Collectively, findings from the three studies that were proposed and completed in 
this staple dissertation project highlighted the important role of FP errors in the 
assessment of yes/no recognition memory, and the utility of more refined RD indices 
derived from the CVLT in elucidating the nature of yes/no recognition memory changes 
associated with healthy aging, and dementia in AD and HD. Furthermore, the present 
findings may inform future research on the utility of refined RD indices in characterizing 
yes/no recognition memory changes associated with preclinical stages of 
neurodegenerative disease, as well as with other neurological conditions involving 
cognitive impairment. 
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APPENDICES 
The following appendices contain supplementary data that were associated with 
the aims addressed in Studies 1, 2, and 3, but were not included in the final published 
manuscripts associated with these studies due to efforts to maintain brevity in the 
production of the individual manuscripts. It is anticipated that these data may be 
incorporated into future manuscripts. 
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APPENDIX A: 
List A vs. List B Recognition Discriminability (RD) in Huntington’s and 
Alzheimer’s Disease 
Preliminary Analyses 
Preliminary ANCOVA tests revealed that age, F(1, 105) = 21.85, p < .001, and 
DRS/DRS-2 scores, F(1, 105) = 30.67, p < .001, were significant predictors of raw scores 
on the List A vs. List B RD index. However, given that scaled scores correct for age, age 
was not included as a covariate in primary analyses involving scaled scores. Moreover, 
given that DRS/DRS-2 scores were systematically varied by group (i.e., individuals with 
HD and AD were characterized as mild or moderate in dementia severity), DRS/DRS-2 
scores were not controlled for in primary analyses involving scaled scores. Gender and 
education were not shown to be significant predictors of raw scores on the List A vs. List 
B RD index (ps > .05). 
Primary Analyses: HD and AD Performance on the List A vs. List B RD Index 
ANOVA tests revealed a significant effect of group on scaled scores on the List A 
vs. List B RD index, F(3, 103) = 4.87, p < .01. Post-hoc pairwise comparisons revealed 
that the HD-mild group outperformed all other HD and AD subgroups (ps < .01). Thus, 
the HD-mild group (M = 6.31, SD = 2.75; p < .01) performed significantly better than the 
HD-mod group (M = 4.44, SD = 2.25), whereas the AD-mild (M = 4.64, SD = 2.02) and 
AD-mod (M = 4.41, SD = 2.10) groups exhibited comparable performance (p > .05). In 
addition, the HD-mild group performed significantly better than the AD-mild group (p < 
.01), whereas the HD-mod and AD-mod groups exhibited comparable performance (p > 
.05). Although the comparison of the HD-mild and AD-mod groups was not of primary 
 114 
interest, post-hoc tests revealed that the former performed significantly better than the 
latter (p < .01). Group differences on scaled scores on the List A vs. List B RD index are 
illustrated in Figure A. 
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Figure A. Mean (standard error) scaled scores on the List A vs. List B RD index in the 
Huntington’s disease-mild (HD-mild), Huntington’s disease-moderate (HD-mod), 
Alzheimer’s disease-mild (AD-mild), and Alzheimer’s disease-moderate (AD-mod) 
groups. 
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APPENDIX B: 
Examination of False Positive (FP) Error Subtypes and Corresponding Source and 
Novel Recognition Discriminability (RD) Indices in Alzheimer’s and Huntington’s 
Disease 
 
Table B.1. Mean (standard deviation) values for the Alzheimer’s disease-moderate (AD-
mod), Alzheimer’s disease-mild (AD-mild), Huntington’s disease-moderate (HD-mod), 
Huntington’s disease-mild (HD-mild), healthy older adult (OA), and healthy middle-aged 
adult (MA) groups on raw scores on Yes/No Recognition variables. 
 
  
Variable AD-mod AD-mild HD-mod HD-mild OA MA
List A vs. List B RD 0.64 (0.58) 0.85 (0.58) 1.14 (0.86) 1.82 (0.90) 2.94 (0.71) 3.17 (0.63)
List A vs. Novel/Prototypical RD 0.54 (0.79) 0.71 (1.06) 1.05 (0.85) 1.25 (0.96) 3.15 (0.89) 3.07 (0.75)
List A vs. Novel/Unrelated RD 1.28 (1.09) 1.78 (1.12) 2.19 (1.10) 2.45 (0.76) 3.50 (0.56) 3.55 (0.52)
List B Shared FP 4.52 (1.97) 4.36 (1.87) 2.75 (2.08) 1.79 (1.99) 0.85 (1.17) 0.65 (1.08)
List B Nonshared FP 4.11 (2.06) 3.52 (2.52) 2.00 (2.19) 1.56 (1.79) 0.83 (1.14) 0.29 (0.69)
Novel/Prototypical FP 4.19 (1.88) 4.00 (2.52) 2.56 (1.79) 3.10 (2.27) 0.66 (1.41) 0.77 (1.06)
Novel/Unrelated FP 2.78 (2.14) 1.80 (2.10) 0.69 (1.62) 0.67 (0.98) 0.08 (0.27) 0.10 (0.30)
Total FP 15.59 (6.17) 13.68 (6.81) 8.00 (5.93) 7.13 (6.17) 2.42 (2.87) 1.81 (1.99)
Total Hits 11.11 (2.99) 11.64 (3.09) 10.63 (3.74) 12.28 (3.04) 14.74 (1.46) 14.94 (1.34)
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Table B.2. p values associated with group differences on raw scores on Yes/No 
Recognition variables in the context of significant group x RD index, and group x FP 
error subtype, interactions in analysis of covariance (ANCOVA) tests. 
 
  
Pairwise Comparison
List A vs. List B 
RD
List A vs. Novel/ 
Prototypical RD
List A vs. Novel/ 
Unrelated RD
List B Shared 
FP
List B 
Nonshared FP
Novel/ 
Prototypical FP
Novel/ 
Unrelated FP
Total Hits Total FP
AD-mod vs. HD-mod .094 .056 <.01* <.01* <.05 <.05 <.001* .909 <.001*
AD-mild vs. HD-mild <.001* <.05 <.01* <.001* <.05 .097 <.01* .280 <.001*
AD-mod vs. AD-mild .292 .427 <.05 .683 .260 .684 <.01 .421 .164
HD-mod vs. HD-mild <.01* .459 .281 .053 .397 .327 .947 <.05 .556
AD-mod vs. HD-mild <.001* <.01 <.001* <.001* <.01* .060 <.001* .104 <.001*
AD-mild vs. HD-mod .314 .151 <.05 <.01 .100 <.05 <.01 .495 <.01*
AD-mod vs. OA <.001* <.001* <.001* <.001* <.001* <.001* <.001* <.001* <.001*
AD-mild vs. OA <.001* <.001* <.001* <.001* <.001* <.001* <.001* <.001* <.001*
HD-mod vs. MA <.001* <.001* <.001* <.001* <.01* <.01* .130 <.001* <.001*
HD-mild vs. MA <.001* <.001* <.001* <.01* <.01* <.001* .064 <.001* <.001*
*p value retains significance following Bonferroni adjustment
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Table B.3. p values for within-group comparisons on raw scores on Yes/No Recognition 
variables in the Alzheimer’s disease-moderate (AD-mod), Alzheimer’s disease-mild (AD-
mild), Huntington’s disease-moderate (HD-mod), and Huntington’s disease-mild (HD-
mild) groups. 
 
 
Pairwise Comparison AD-mod AD-mild HD-mod HD-mild
List A vs. List B RD - List A vs. Novel/Prototyical RD .207 .153 .991 <.01*
List A vs. List B RD - List A vs. Novel/Unrelated RD <.01* <.001* <.001* <.001*
List A vs. Novel/Prototypial RD - List A vs. Novel/Unrelated RD <.01* <.001* <.001* <.001*
List B Shared FP - List B Nonshared FP .065 <.01* .411 .740
List B Shared FP - Novel/Prototypical FP .342 .293 .718 <.001*
List B Shared FP - Novel/Unrelated FP <.001* <.001* <.001* <.001*
List B Nonshared FP - Novel/Prototypical FP .406 .118 .677 <.01*
List B Nonshared FP - Novel/Unrelated FP <.05 <.001* <.001* <.001*
Novel/Prototypical FP - Novel/Unrelated FP <.01* <.001* <.001* <.001*
*p value retains significance following Bonferroni adjustment
